,pathway_name,pathway_id,pathway_type,pathway_class
0,KEGG_MEDICUS_ENV_FACTOR_ARSENIC_TO_ELECTRON_TRANSFER_IN_COMPLEX_IV,N01394,Env factor,Mitochondrial ROS formation
1,KEGG_MEDICUS_ENV_FACTOR_BENZO_A_PYRENRE_TO_CYP_MEDIATED_METABOLISM,N01401,Env factor,CYP-mediated ROS formation
2,KEGG_MEDICUS_ENV_FACTOR_BPA_TO_RAS_ERK_SIGNALING_PATHWAY,N01352,Env factor,ERK signaling
3,KEGG_MEDICUS_ENV_FACTOR_DCE_TO_DNA_ADDUCTS,N01386,Env factor,DNA adduct formation
4,KEGG_MEDICUS_ENV_FACTOR_E2_TO_NUCLEAR_INITIATED_ESTROGEN_SIGNALING_PATHWAY,N01364,Env factor,Nuclear receptor signaling
5,KEGG_MEDICUS_ENV_FACTOR_E2_TO_RAS_ERK_SIGNALING_PATHWAY,N01353,Env factor,ERK signaling
6,KEGG_MEDICUS_ENV_FACTOR_IRON_TO_ANTEROGRADE_AXONAL_TRANSPORT,N01414,Env factor,Alzheimer disease
7,KEGG_MEDICUS_ENV_FACTOR_METALS_TO_JNK_SIGNALING_PATHWAY,N01407,Env factor,Other MAPK signaling
8,KEGG_MEDICUS_ENV_FACTOR_METALS_TO_KEAP1_NRF2_SIGNALIG_PATHWAY,N01413,Env factor,KEAP1-NRF2 signaling
9,KEGG_MEDICUS_ENV_FACTOR_METALS_TO_NFKB_SIGNALING_PATHWAY,N01411,Env factor,TNF signaling
10,KEGG_MEDICUS_ENV_FACTOR_METALS_TO_RAS_ERK_SIGNALING_PATHWAY,N01408,Env factor,ERK signaling
11,KEGG_MEDICUS_ENV_FACTOR_NICOTINE_NNK_TO_CAMP_SIGNALING_PATHWAY,N01346,Env factor,cAMP signaling
12,KEGG_MEDICUS_ENV_FACTOR_NICOTINE_NNK_TO_PI3K_SIGNALING_PATHWAY,N01348,Env factor,PI3K signaling
13,KEGG_MEDICUS_ENV_FACTOR_NNK_NNN_TO_CHRNA7_E2F_SIGNALING_PATHWAY,N01337,Env factor,Cell cycle
14,KEGG_MEDICUS_ENV_FACTOR_NNK_NNN_TO_PI3K_SIGNALING_PATHWAY_N01339,N01339,Env factor,PI3K signaling
15,KEGG_MEDICUS_ENV_FACTOR_NNK_NNN_TO_PI3K_SIGNALING_PATHWAY_N01350,N01350,Env factor,PI3K signaling
16,KEGG_MEDICUS_ENV_FACTOR_NNK_NNN_TO_RAS_ERK_SIGNALING_PATHWAY,N01344,Env factor,ERK signaling
17,KEGG_MEDICUS_ENV_FACTOR_NNK_TO_DNA_ADDUCTS,N01381,Env factor,DNA adduct formation
18,KEGG_MEDICUS_ENV_FACTOR_PHIP_TO_DNA_ADDUCTS,N01371,Env factor,DNA adduct formation
19,KEGG_MEDICUS_ENV_FACTOR_TCDD_TO_AHR_SIGNALING_PATHWAY,N01365,Env factor,Nuclear receptor signaling
20,KEGG_MEDICUS_ENV_FACTOR_ZN_TO_ANTEROGRADE_AXONAL_TRANSPORT,N01403,Env factor,Alzheimer disease
21,KEGG_MEDICUS_PATHOGEN_ARSENIC_TO_ELECTRON_TRANSFER_IN_COMPLEX_II,N01392,Pathogen,Mitochondrial ROS formation
22,KEGG_MEDICUS_PATHOGEN_EBV_BARF1_TO_INTRINSIC_APOPTOTIC_PATHWAY,N00478,Pathogen,Epstein-Barr virus (EBV)
23,KEGG_MEDICUS_PATHOGEN_EBV_EBNA1_TO_P53_MEDIATED_TRANSCRIPTION,N00223,Pathogen,Epstein-Barr virus (EBV)
24,KEGG_MEDICUS_PATHOGEN_EBV_EBNA2_TO_RBP_JK_MEDIATED_TRANSCRIPTION,N00225,Pathogen,Epstein-Barr virus (EBV)
25,KEGG_MEDICUS_PATHOGEN_EBV_EBNA3C_TO_CELL_CYCLE_G1_S,N00483,Pathogen,Epstein-Barr virus (EBV)
26,KEGG_MEDICUS_PATHOGEN_EBV_EBNA3C_TO_P27_CELL_CYCLE_G1_S_N00264,N00264,Pathogen,Epstein-Barr virus (EBV)
27,KEGG_MEDICUS_PATHOGEN_EBV_EBNA3C_TO_P27_CELL_CYCLE_G1_S_N00482,N00482,Pathogen,Epstein-Barr virus (EBV)
28,KEGG_MEDICUS_PATHOGEN_EBV_EBNA3C_TO_P53_MEDIATED_TRANSCRIPTION,N00263,Pathogen,Epstein-Barr virus (EBV)
29,KEGG_MEDICUS_PATHOGEN_EBV_LMP1_TO_NFKB_SIGNALING_PATHWAY,N00265,Pathogen,TNF signaling
30,KEGG_MEDICUS_PATHOGEN_ESCHERICHIA_EAE_TIR_TCCP_TO_ACTIN_SIGNALING_PATHWAY,N01094,Pathogen,Cytoskeletal regulation (viruses and bacteria)
31,KEGG_MEDICUS_PATHOGEN_ESCHERICHIA_EAE_TIR_TO_ACTIN_SIGNALING_PATHWAY,N01092,Pathogen,Cytoskeletal regulation (viruses and bacteria)
32,KEGG_MEDICUS_PATHOGEN_ESCHERICHIA_ESPG_TO_MICROTUBULE_RHOA_SIGNALING_PATHWAY,N01286,Pathogen,Cytoskeletal regulation (viruses and bacteria)
33,KEGG_MEDICUS_PATHOGEN_ESCHERICHIA_ESPT_TO_RAC_SIGNALING_PATHWAY,N01086,Pathogen,Cytoskeletal regulation (viruses and bacteria)
34,KEGG_MEDICUS_PATHOGEN_ESCHERICHIA_MAP_TO_CDC42_SIGNALING_PATHWAY,N01096,Pathogen,Cytoskeletal regulation (viruses and bacteria)
35,KEGG_MEDICUS_PATHOGEN_HBV_HBX_TO_CREB_MEDIATED_TRANSCRIPTION,N00544,Pathogen,Hepatocellular carcinoma
36,KEGG_MEDICUS_PATHOGEN_HBV_HBX_TO_RAS_ERK_SIGNALING_PATHWAY,N00540,Pathogen,Hepatocellular carcinoma
37,KEGG_MEDICUS_PATHOGEN_HBV_LHBS_TO_PKC_ERK_SIGNALING_PATHWAY,N00547,Pathogen,Hepatocellular carcinoma
38,KEGG_MEDICUS_PATHOGEN_HCMV_GB_TO_PDGFR_RAS_ERK_SIGNALING_PATHWAY,N00386,Pathogen,Human cytomegalovirus (HCMV)
39,KEGG_MEDICUS_PATHOGEN_HCMV_GH_TO_ITGA_B_RHOA_SIGNALING_PATHWAY,N00394,Pathogen,Human cytomegalovirus (HCMV)
40,KEGG_MEDICUS_PATHOGEN_HCMV_UL33_TO_GNAI_AC_PKA_SIGNALING_PATHWAY,N00412,Pathogen,Human cytomegalovirus (HCMV)
41,KEGG_MEDICUS_PATHOGEN_HCMV_UL33_TO_GNAQ_PLCB_G_CALCINEURIN_SIGNALING_PATHWAY,N00407,Pathogen,Human cytomegalovirus (HCMV)
42,KEGG_MEDICUS_PATHOGEN_HCMV_UL33_TO_GNAS_AC_PKA_SIGNALING_PATHWAY,N00411,Pathogen,Human cytomegalovirus (HCMV)
43,KEGG_MEDICUS_PATHOGEN_HCMV_UL33_TO_GNB_G_RHO_SIGNALING_PATHWAY,N00409,Pathogen,Human cytomegalovirus (HCMV)
44,KEGG_MEDICUS_PATHOGEN_HCMV_US27_TO_CXCR4_GNB_G_PLCB_PKC_SIGNALING_PATHWAY,N00414,Pathogen,Human cytomegalovirus (HCMV)
45,KEGG_MEDICUS_PATHOGEN_HCMV_US28_TO_GNA12_13_RHO_SIGNALING_PATHWAY,N00406,Pathogen,Human cytomegalovirus (HCMV)
46,KEGG_MEDICUS_PATHOGEN_HCMV_US28_TO_GNAI_AC_PKA_SIGNALING_PATHWAY,N00404,Pathogen,Human cytomegalovirus (HCMV)
47,KEGG_MEDICUS_PATHOGEN_HCMV_US28_TO_GNAQ_PLCB_G_CALCINEURIN_SIGNALING_PATHWAY,N00402,Pathogen,Human cytomegalovirus (HCMV)
48,KEGG_MEDICUS_PATHOGEN_HCMV_US28_TO_GNB_G_PI3K_NFKB_SIGNALING_PATHWAY,N00400,Pathogen,Human cytomegalovirus (HCMV)
49,KEGG_MEDICUS_PATHOGEN_HCV_CORE_TO_ERK_SIGNALING_PATHWAY,N00518,Pathogen,Hepatocellular carcinoma
50,KEGG_MEDICUS_PATHOGEN_HCV_CORE_TO_RXRA_LXRA_MEDIATED_TRANSCRIPTION,N00530,Pathogen,Hepatocellular carcinoma
51,KEGG_MEDICUS_PATHOGEN_HIV_GP120_TO_CXCR4_GNAI_PI3K_BAD_SIGNALING_PATHWAY,N00431,Pathogen,Human immunodeficiency virus 1 (HIV-1)
52,KEGG_MEDICUS_PATHOGEN_HIV_GP120_TO_CXCR4_GNAQ_PLCB_G_CALCINEURIN,N00432,Pathogen,Human immunodeficiency virus 1 (HIV-1)
53,KEGG_MEDICUS_PATHOGEN_HIV_GP120_TO_CXCR4_GNB_G_RAC_SIGNALING_PATHWAY,N00434,Pathogen,Human immunodeficiency virus 1 (HIV-1)
54,KEGG_MEDICUS_PATHOGEN_HIV_GP120_TO_TNF_NFKB_SIGNALING_PATHWAY,N00441,Pathogen,TNF signaling
55,KEGG_MEDICUS_PATHOGEN_HIV_NEF_TO_TNF_NFKB_SIGNALING_PATHWAY,N00442,Pathogen,TNF signaling
56,KEGG_MEDICUS_PATHOGEN_HIV_TAT_NEF_TO_CROSSTALK_BETWEEN_EXTRINSIC_AND_INTRINSIC_APOPTOTIC_PATHWAYS,N00449,Pathogen,Human immunodeficiency virus 1 (HIV-1)
57,KEGG_MEDICUS_PATHOGEN_HIV_TAT_TO_TLR2_4_NFKB_SIGNALING_PATHWAY,N00436,Pathogen,TLR signaling
58,KEGG_MEDICUS_PATHOGEN_HIV_VPR_TAT_TO_TNF_JNK_SIGNALING_PATHWAY,N00447,Pathogen,TNF signaling
59,KEGG_MEDICUS_PATHOGEN_HIV_VPR_TO_CDC25_CELL_CYCLE_G2M,N00456,Pathogen,Human immunodeficiency virus 1 (HIV-1)
60,KEGG_MEDICUS_PATHOGEN_HPV_E5_TO_ANTIGEN_PROCESSING_AND_PRESENTATION_BY_MHC_CLASS_I_MOLECULES,N00364,Pathogen,Human papillomavirus (HPV)
61,KEGG_MEDICUS_PATHOGEN_HPV_E5_TO_EGFR_RAS_ERK_SIGNALING_PATHWAY,N00367,Pathogen,Human papillomavirus (HPV)
62,KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00380,N00380,Pathogen,NOTCH signaling
63,KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00381,N00381,Pathogen,NOTCH signaling
64,KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00382,N00382,Pathogen,NOTCH signaling
65,KEGG_MEDICUS_PATHOGEN_HPV_E7_TO_CELL_CYCLE_G1_S,N00361,Pathogen,Human papillomavirus (HPV)
66,KEGG_MEDICUS_PATHOGEN_HPV_E7_TO_P27_CELL_CYCLE_G1_S,N00360,Pathogen,Human papillomavirus (HPV)
67,KEGG_MEDICUS_PATHOGEN_HPV_E7_TO_PP2A_AKT_SIGNALING_PATYWAY,N00356,Pathogen,PI3K signaling
68,KEGG_MEDICUS_PATHOGEN_HSV_GD_TO_HVEM_NFKB_SIGNALING_PATHWAY,N00560,Pathogen,TNF signaling
69,KEGG_MEDICUS_PATHOGEN_HTLV_1_P12_TO_ANTIGEN_PROCESSING_AND_PRESENTATION_BY_MHC_CLASS_I_MOLECULES,N00492,Pathogen,MHC presentation
70,KEGG_MEDICUS_PATHOGEN_HTLV_1_P12_TO_JAK_STAT_SIGNALING_PATHWAY,N00491,Pathogen,JAK-STAT signaling
71,KEGG_MEDICUS_PATHOGEN_HTLV_1_TAX_TO_NFY_MEDIATED_TRANSCRIPTION,N00508,Pathogen,Human T-cell leukemia virus 1 (HTLV-1)
72,KEGG_MEDICUS_PATHOGEN_HTLV_1_TAX_TO_P21_CELL_CYCLE_G1_S_N00497,N00497,Pathogen,Human T-cell leukemia virus 1 (HTLV-1)
73,KEGG_MEDICUS_PATHOGEN_HTLV_1_TAX_TO_P21_CELL_CYCLE_G1_S_N00498,N00498,Pathogen,Human T-cell leukemia virus 1 (HTLV-1)
74,KEGG_MEDICUS_PATHOGEN_HTLV_1_TAX_TO_SPINDLE_ASSEMBLY_CHECKPOINT_SIGNALING,N00221,Pathogen,Cell cycle
75,KEGG_MEDICUS_PATHOGEN_KSHV_K15_TO_TNF_NFKB_SIGNALING_PATHWAY,N00173,Pathogen,TNF signaling
76,KEGG_MEDICUS_PATHOGEN_KSHV_LANA_TO_WNT_SIGNALING_PATHWAY,N00175,Pathogen,WNT signaling
77,KEGG_MEDICUS_PATHOGEN_KSHV_MIR1_2_TO_ANTIGEN_PROCESSING_AND_PRESENTATION_BY_MHC_CLASS_I_MOLECULES,N00184,Pathogen,MHC presentation
78,KEGG_MEDICUS_PATHOGEN_KSHV_MIR2_TO_CELL_SURFACE_MOLECULE_ENDOCYTOSIS,N00185,Pathogen,MHC presentation
79,KEGG_MEDICUS_PATHOGEN_KSHV_VCYCLIN_TO_CELL_CYCLE_G1_S,N00168,Pathogen,Cell cycle
80,KEGG_MEDICUS_PATHOGEN_KSHV_VFLIP_TO_NFKB_SIGNALING_PATHWAY,N00171,Pathogen,TNF signaling
81,KEGG_MEDICUS_PATHOGEN_KSHV_VFLIP_TO_TNF_NFKB_SIGNALING_PATHWAY,N00174,Pathogen,TNF signaling
82,KEGG_MEDICUS_PATHOGEN_KSHV_VGPCR_TO_GNB_G_ERK_SIGNALING_PATHWAY,N00157,Pathogen,CXCR signaling
83,KEGG_MEDICUS_PATHOGEN_KSHV_VGPCR_TO_GNB_G_PI3K_AKT_SIGNALING_PATHWAY,N00158,Pathogen,CXCR signaling
84,KEGG_MEDICUS_PATHOGEN_KSHV_VGPCR_TO_GNB_G_PI3K_JNK_SIGNALING_PATHWAY,N00178,Pathogen,CXCR signaling
85,KEGG_MEDICUS_PATHOGEN_SALMONELLA_AVRA_TO_BETA_CATENIN_SIGNALING_PATHWAY,N01124,Pathogen,WNT signaling
86,KEGG_MEDICUS_PATHOGEN_SALMONELLA_SIFA_TO_MICROTUBULE_PLUS_END_DIRECTED_TRANSPORT,N01298,Pathogen,Membrane trafficking (bacteria)
87,KEGG_MEDICUS_PATHOGEN_SALMONELLA_SIFA_TO_TETHERING_OF_LATE_ENDOSOMES_AND_LYSOSOMES,N01301,Pathogen,Membrane trafficking (bacteria)
88,KEGG_MEDICUS_PATHOGEN_SALMONELLA_SOPB_TO_ANXA2_S100A10_REGULATED_ACTIN_CYTOSKELETON,N01305,Pathogen,Cytoskeletal regulation (viruses and bacteria)
89,KEGG_MEDICUS_PATHOGEN_SALMONELLA_SOPB_TO_ARNO_ARF_ACTB_G_SIGNALING_PATHWAY,N01129,Pathogen,Cytoskeletal regulation (viruses and bacteria)
90,KEGG_MEDICUS_PATHOGEN_SALMONELLA_SOPB_TO_RHOA_SIGNALING_PATHWAY,N01130,Pathogen,Cytoskeletal regulation (viruses and bacteria)
91,KEGG_MEDICUS_PATHOGEN_SALMONELLA_SOPE_E2_TO_NOD_NFKB_SIGNALING_PATHWAY,N01112,Pathogen,NLR signaling
92,KEGG_MEDICUS_PATHOGEN_SALMONELLA_SOPE_TO_RAC_SIGNALING_PATHWAY,N01128,Pathogen,Cytoskeletal regulation (viruses and bacteria)
93,KEGG_MEDICUS_PATHOGEN_SARS_COV_2_NSP1_TO_TRANSLATION_INITIATION,N01318,Pathogen,SARS coronavirus 2 (SARS-CoV-2)
94,KEGG_MEDICUS_PATHOGEN_SARS_COV_2_S_N_TO_LECTIN_PATHWAY_OF_COAGULATION_CASCADE,N01316,Pathogen,SARS coronavirus 2 (SARS-CoV-2)
95,KEGG_MEDICUS_PATHOGEN_SARS_COV_2_S_TO_ANGII_AT1R_NOX2_SIGNALING_PATHWAY,N01307,Pathogen,SARS coronavirus 2 (SARS-CoV-2)
96,KEGG_MEDICUS_PATHOGEN_SARS_COV_2_S_TO_CLASSICAL_PATHWAY_OF_COMPLEMENT_CASCADE,N01314,Pathogen,Complement cascade
97,KEGG_MEDICUS_PATHOGEN_SHIGELLA_FIMA_TO_CROSSTALK_BETWEEN_EXTRINSIC_AND_INTRINSIC_APOPTOTIC_PATHWAYS,N00950,Pathogen,Apoptosis
98,KEGG_MEDICUS_PATHOGEN_SHIGELLA_IPAA_TO_ITGA_B_RHOGEF_RHOA_SIGNALING_PATHWAY,N01074,Pathogen,Cytoskeletal regulation (viruses and bacteria)
99,KEGG_MEDICUS_PATHOGEN_SHIGELLA_IPAB_C_D_TO_ITGA_B_TALIN_VINCULIN_SIGNALING_PATHWAY,N01081,Pathogen,Cytoskeletal regulation (viruses and bacteria)
100,KEGG_MEDICUS_PATHOGEN_SHIGELLA_IPAC_TO_ACTIN_SIGNALING_PATHWAY,N01079,Pathogen,Cytoskeletal regulation (viruses and bacteria)
101,KEGG_MEDICUS_PATHOGEN_SHIGELLA_IPGD_TO_ARNO_ARF_ACTB_G_SIGNALING_PATHWAY,N01067,Pathogen,Cytoskeletal regulation (viruses and bacteria)
102,KEGG_MEDICUS_PATHOGEN_SHIGELLA_OSPF_TO_TLR2_4_MAPK_SIGNALING_PATHWAY,N01283,Pathogen,TLR signaling
103,KEGG_MEDICUS_PATHOGEN_SHIGELLA_OSPG_TO_TNF_NFKB_SIGNALING_PATHWAY,N00942,Pathogen,TNF signaling
104,KEGG_MEDICUS_PATHOGEN_YERSINIA_YOPP_J_TO_TLR2_4_MAPK_SIGNALING_PATHWAY,N00862,Pathogen,TLR signaling
105,KEGG_MEDICUS_REFERENCE_26S_PROTEASOME_MEDIATED_PROTEIN_DEGRADATION,N01029,Reference,Alzheimer disease
106,KEGG_MEDICUS_REFERENCE_ACH_CHRN_PI3K_SIGNALING_PATHWAY,N01338,Reference,PI3K signaling
107,KEGG_MEDICUS_REFERENCE_ACH_CHRN_RAS_ERK_SIGNALING_PATHWAY,N01343,Reference,ERK signaling
108,KEGG_MEDICUS_REFERENCE_ACTH_CORTISOL_SIGNALING_PATHWAY,N00297,Reference,CRH-ACTH-cortisol signaling
109,KEGG_MEDICUS_REFERENCE_ACTIVATION_OF_PRC2.2_BY_UBIQUITINATION_OF_H2AK119,N01586,Reference,Epigenetic regulation by Polycomb complexes
110,KEGG_MEDICUS_REFERENCE_ACTIVATION_OF_PRC2.2_BY_UBIQUITINATION_OF_H2AK119_IN_GERMLINE_GENES,N01614,Reference,Epigenetic regulation by Polycomb complexes
111,KEGG_MEDICUS_REFERENCE_ACTIVIN_SIGNALING_PATHWAY,N01456,Reference,TGFB signaling
112,KEGG_MEDICUS_REFERENCE_ADRB3_UCP1_SIGNALING_PATHWAY,N01688,Reference,Thermogenesis
113,KEGG_MEDICUS_REFERENCE_AGE_RAGE_SIGNALING_PATHWAY,N00994,Reference,Alzheimer disease
114,KEGG_MEDICUS_REFERENCE_AHR_SIGNALING_PATHWAY,N00317,Reference,Nuclear receptor signaling
115,KEGG_MEDICUS_REFERENCE_ALTERNATIVE_PATHWAY_OF_COMPLEMENT_CASCADE_C3B_BREAKDOWN,N01496,Reference,Complement cascade
116,KEGG_MEDICUS_REFERENCE_AMH_SIGNALING_PATHWAY,N01454,Reference,TGFB signaling
117,KEGG_MEDICUS_REFERENCE_ANGII_AT1R_NOX2_SIGNALING_PATHWAY,N01306,Reference,SARS coronavirus 2 (SARS-CoV-2)
118,KEGG_MEDICUS_REFERENCE_ANGIOTENSIN_ALDOSTERONE_SIGNALING_PATHWAY,N00301,Reference,Renin-angiotensin-aldosterone signaling
119,KEGG_MEDICUS_REFERENCE_ANTEROGRADE_AXONAL_TRANSPORT,N00978,Reference,Alzheimer disease
120,KEGG_MEDICUS_REFERENCE_ANTIGEN_PROCESSING_AND_PRESENTATION_BY_MHC_CLASS_II_MOLECULES,N00590,Reference,Herpes simplex virus 1 (HSV-1)
121,KEGG_MEDICUS_REFERENCE_ANTIGEN_PROCESSING_AND_PRESENTATION_BY_MHC_CLASS_I_MOLECULES,N00363,Reference,MHC presentation
122,KEGG_MEDICUS_REFERENCE_AREG_EGFR_PI3K_SIGNALING_PATHWAY,N00284,Reference,Colorectal cancer
123,KEGG_MEDICUS_REFERENCE_AREG_EGFR_RAS_ERK_SIGNALING_PATHWAY,N00279,Reference,Colorectal cancer
124,KEGG_MEDICUS_REFERENCE_ARL8_REGULATED_MICROTUBULE_PLUS_END_DIRECTED_TRANSPORT,N01297,Reference,Membrane trafficking (bacteria)
125,KEGG_MEDICUS_REFERENCE_ARNO_ARF_ACTB_G_SIGNALING_PATHWAY,N01066,Reference,Cytoskeletal regulation (viruses and bacteria)
126,KEGG_MEDICUS_REFERENCE_ASSEMBLY_AND_TRAFFICKING_OF_TELOMERASE,N01476,Reference,Telomere length regulation
127,KEGG_MEDICUS_REFERENCE_ATR_P21_CELL_CYCLE_G2_M,N00499,Reference,Cell cycle
128,KEGG_MEDICUS_REFERENCE_ATR_SIGNALING,N01451,Reference,Double-strand break repair
129,KEGG_MEDICUS_REFERENCE_AUTOPHAGOSOME_AND_LYSOSOME_FUSION_TETHERING_FACTOR,N01721,Reference,Autophagy
130,KEGG_MEDICUS_REFERENCE_AUTOPHAGOSOME_AND_LYSOSOME_FUSION_TETHERING_FACTOR_GRASP55,N01722,Reference,Autophagy
131,KEGG_MEDICUS_REFERENCE_AUTOPHAGY_VESICLE_NUCLEATION_ELONGATION_MATURATION_E3_UBIQUITIN_LIGASE_MALIN,N01719,Reference,Autophagy
132,KEGG_MEDICUS_REFERENCE_AUTOPHAGY_VESICLE_NUCLEATION_ELONGATION_MATURATION_LC3_II_FORMATION,N00156,Reference,Autophagy
133,KEGG_MEDICUS_REFERENCE_AUTOPHAGY_VESICLE_NUCLEATION_ELONGATION_MATURATION_MTORC1_PI3KC3_C1,N00155,Reference,Autophagy
134,KEGG_MEDICUS_REFERENCE_AUTOPHAGY_VESICLE_NUCLEATION_ELONGATION_MATURATION_PACER_RUBCN_PI3KC3_C2,N01718,Reference,Autophagy
135,KEGG_MEDICUS_REFERENCE_AUTOPHAGY_VESICLE_NUCLEATION_ELONGATION_MATURATION_PI3P_SYNTHESIS_BY_PI3KC3_C1,N01715,Reference,Autophagy
136,KEGG_MEDICUS_REFERENCE_AUTOPHAGY_VESICLE_NUCLEATION_ELONGATION_MATURATION_SEQUESTOSOME_1_LIKE_RECEPTOR,N01716,Reference,Autophagy
137,KEGG_MEDICUS_REFERENCE_AVP_V2R_PKA_SIGNALING_PATHWAY,N00915,Reference,AVP signaling
138,KEGG_MEDICUS_REFERENCE_BASE_EXCISION_AND_STRAND_CLEAVAGE_BY_BIFUNCTIONAL_GLYCOSYLASE,N01434,Reference,Base excision repair
139,KEGG_MEDICUS_REFERENCE_BASE_EXCISION_AND_STRAND_CLEAVAGE_BY_MONOFUNCTIONAL_GLYCOSYLASE,N01433,Reference,Base excision repair
140,KEGG_MEDICUS_REFERENCE_BASE_EXCISION_AND_STRAND_CLEAVAGE_BY_NEIL_GLYCOSYLASE,N01435,Reference,Base excision repair
141,KEGG_MEDICUS_REFERENCE_BCR_BCAP_CD19_PI3K_SIGNALING_PATHWAY,N01695,Reference,PI3K signaling
142,KEGG_MEDICUS_REFERENCE_BCR_PLCG_CALCINEURIN_SIGNALING_PATHWAY,N00487,Reference,Calcium signaling
143,KEGG_MEDICUS_REFERENCE_BCR_PLCG_ITPR_SIGNALING_PATHWAY,N01463,Reference,Calcium signaling
144,KEGG_MEDICUS_REFERENCE_BETA_OXIDATION,N00804,Reference,beta-Oxidation in mitochondria
145,KEGG_MEDICUS_REFERENCE_BETA_OXIDATION_ACYL_COA_SYNTHESIS,N00765,Reference,beta-Oxidation in mitochondria
146,KEGG_MEDICUS_REFERENCE_BILE_ACID_BIOSYNTHESIS,N00805,Reference,Bile acid biosynthesis
147,KEGG_MEDICUS_REFERENCE_BLOCKING_UBIQUITINATION_OF_H2AK119_BY_CK2,N01620,Reference,Epigenetic regulation by Polycomb complexes
148,KEGG_MEDICUS_REFERENCE_BLOOD_GROUP_H_O_ANTIGEN_TYPE_1_BIOSYNTHESIS,N01651,Reference,Blood group carbohydrate antigen biosynthesis
149,KEGG_MEDICUS_REFERENCE_BLOOD_GROUP_H_O_ANTIGEN_TYPE_2_BIOSYNTHESIS,N01666,Reference,Blood group carbohydrate antigen biosynthesis
150,KEGG_MEDICUS_REFERENCE_BMP15_SIGNALING_PATHWAY,N01455,Reference,TGFB signaling
151,KEGG_MEDICUS_REFERENCE_BMP9_10_SIGNALING_PATHWAY,N01426,Reference,TGFB signaling
152,KEGG_MEDICUS_REFERENCE_BMP_HAMP_SIGNALING_PATHWAY,N01458,Reference,TGFB signaling
153,KEGG_MEDICUS_REFERENCE_BMP_HAMP_SIGNALING_PATHWAY_AUXILIARY_FACTOR,N01461,Reference,TGFB signaling
154,KEGG_MEDICUS_REFERENCE_BMP_SIGNALING_PATHWAY,N01453,Reference,TGFB signaling
155,KEGG_MEDICUS_REFERENCE_BMP_SIGNALING_PATHWAY_BMP_ANTAGONIST,N01428,Reference,TGFB signaling
156,KEGG_MEDICUS_REFERENCE_BRANCHING_MICROTUBULE_NUCLEATION,N01549,Reference,Regulation of kinetochore-microtubule interactions
157,KEGG_MEDICUS_REFERENCE_BREAK_INDUCED_REPLICATION,N01450,Reference,Double-strand break repair
158,KEGG_MEDICUS_REFERENCE_C9ORF72_MEDIATED_AUTOPHAGY_INITIATION,N01142,Reference,Autophagy
159,KEGG_MEDICUS_REFERENCE_CA2_CAM_CAMK_SIGNALING_PATHWAY,N01648,Reference,Calcium signaling
160,KEGG_MEDICUS_REFERENCE_CA2_CAM_CN_SIGNALING_PATHWAY,N01647,Reference,Calcium signaling
161,KEGG_MEDICUS_REFERENCE_CA2_CAM_VGCC_RYR_SIGNALING_PATHWAY,N01649,Reference,Calcium signaling
162,KEGG_MEDICUS_REFERENCE_CA2_ENTRY_LIGAND_GATED_CA2_CHANNEL,N01642,Reference,Calcium signaling
163,KEGG_MEDICUS_REFERENCE_CA2_ENTRY_VOLTAGE_GATED_CA2_CHANNEL,N01637,Reference,Calcium signaling
164,KEGG_MEDICUS_REFERENCE_CA2_PLCD_ITPR_SIGNALING_PATHWAY,N01655,Reference,Calcium signaling
165,KEGG_MEDICUS_REFERENCE_CA2_PYK2_RAS_ERK_SIGNALING_PATHWAY,N00538,Reference,MAPK signaling
166,KEGG_MEDICUS_REFERENCE_CARDIAC_TYPE_VGCC_RYR_SIGNALING,N01639,Reference,Calcium signaling
167,KEGG_MEDICUS_REFERENCE_CASR_PTH_SIGNALING_PATHWAY,N00291,Reference,CaSR-PTH signaling
168,KEGG_MEDICUS_REFERENCE_CCR2_GNB_G_PI3K_NFKB_SIGNALING_PATHWAY,N00399,Reference,Human cytomegalovirus (HCMV)
169,KEGG_MEDICUS_REFERENCE_CCR5_GNB_G_PLCB_G_PKC_SIGNALING_PATHWAY,N00428,Reference,Human cytomegalovirus (HCMV)
170,KEGG_MEDICUS_REFERENCE_CCR_CXCR_GNB_G_PI3K_RAC_SIGNALING_PATHWAY,N00153,Reference,CXCR signaling
171,KEGG_MEDICUS_REFERENCE_CD40_NFKB_SIGNALING_PATHWAY,N00505,Reference,TNF signaling
172,KEGG_MEDICUS_REFERENCE_CD80_CD86_CD28_PI3K_SIGNALING_PATHWAY,N00683,Reference,PI3K signaling
173,KEGG_MEDICUS_REFERENCE_CD80_CD86_CTLA4_PP2A_SIGNALING_PATHWAY,N01579,Reference,PI3K signaling
174,KEGG_MEDICUS_REFERENCE_CDC25_CELL_CYCLE_G2_M,N00455,Reference,Human immunodeficiency virus 1 (HIV-1)
175,KEGG_MEDICUS_REFERENCE_CENPE_INTERACTION_WITH_NDC80_COMPLEX,N01531,Reference,Regulation of kinetochore-microtubule interactions
176,KEGG_MEDICUS_REFERENCE_CGAS_STING_SIGNALING_PATHWAY,N00395,Reference,CGAS-STING signaling
177,KEGG_MEDICUS_REFERENCE_CHOLESTEROL_BIOSYNTHESIS,N01624,Reference,Cholesterol biosynthesis
178,KEGG_MEDICUS_REFERENCE_CHONDROITIN_SULFATE_BIOSYNTHESIS,N01580,Reference,Glycosaminoglycan biosynthesis
179,KEGG_MEDICUS_REFERENCE_CHRNA7_E2F_SIGNALING_PATHWAY,N01336,Reference,Cell cycle
180,KEGG_MEDICUS_REFERENCE_CITRATE_CYCLE_FIRST_CARBON_OXIDATION,N01604,Reference,Citrate cycle and pyruvate metabolism
181,KEGG_MEDICUS_REFERENCE_CITRATE_CYCLE_SECOND_CARBON_OXIDATION_2,N01617,Reference,Citrate cycle and pyruvate metabolism
182,KEGG_MEDICUS_REFERENCE_CLASSICAL_PATHWAY_OF_COMPLEMENT_CASCADE_C4_C2_TO_C3_CONVERTASE_FORMATION,N01487,Reference,Complement cascade
183,KEGG_MEDICUS_REFERENCE_COHESIN_DISSOCIATION_IN_ANAPHASE,N01486,Reference,Chromosome cohesion and segregation
184,KEGG_MEDICUS_REFERENCE_COHESIN_DISSOCIATION_IN_PROPHASE,N01485,Reference,Chromosome cohesion and segregation
185,KEGG_MEDICUS_REFERENCE_COHESIN_LOADING,N01482,Reference,Chromosome cohesion and segregation
186,KEGG_MEDICUS_REFERENCE_COMMON_PATHWAY_OF_COMPLEMENT_CASCADE_MAC_FORMATION,N01490,Reference,Complement cascade
187,KEGG_MEDICUS_REFERENCE_CONDENSIN_LOADING,N01497,Reference,Chromosome cohesion and segregation
188,KEGG_MEDICUS_REFERENCE_COPII_VESICLE_FORMATION,N01289,Reference,Membrane trafficking (bacteria)
189,KEGG_MEDICUS_REFERENCE_COPI_VESICLE_FORMATION,N01293,Reference,Membrane trafficking (bacteria)
190,KEGG_MEDICUS_REFERENCE_CORE_NER_REACTION,N01431,Reference,Nucleotide excision repair
191,KEGG_MEDICUS_REFERENCE_CREATINE_PATHWAY,N01612,Reference,"Glycine,serine and arginine metabolism"
192,KEGG_MEDICUS_REFERENCE_CRHR_PKA_ACTH_SIGNALING_PATHWAY,N00324,Reference,CRH-ACTH-cortisol signaling
193,KEGG_MEDICUS_REFERENCE_CROSSTALK_BETWEEN_EXTRINSIC_AND_INTRINSIC_APOPTOTIC_PATHWAYS,N00146,Reference,Apoptosis
194,KEGG_MEDICUS_REFERENCE_CX3CR1_GNAI_AC_PKA_SIGNALING_PATHWAY,N00403,Reference,Human cytomegalovirus (HCMV)
195,KEGG_MEDICUS_REFERENCE_CXCL12_CXCR4_PKC_ERK_SIGNALING_PATHAWAY,N00546,Reference,Hepatocellular carcinoma
196,KEGG_MEDICUS_REFERENCE_CXCR4_GNA12_13_RHO_SIGNALING_PATHWAY,N00405,Reference,Human cytomegalovirus (HCMV)
197,KEGG_MEDICUS_REFERENCE_CXCR4_GNAI_PI3K_BAD_SIGNALING_PATHWAY,N00430,Reference,Human immunodeficiency virus 1 (HIV-1)
198,KEGG_MEDICUS_REFERENCE_CXCR4_GNAQ_PLCB_G_CALCINEURIN_SIGNALING_PATHWAY,N00401,Reference,Human immunodeficiency virus 1 (HIV-1)
199,KEGG_MEDICUS_REFERENCE_CXCR4_GNB_G_PLCB_PKC_SIGNALING_PATHWAY,N00413,Reference,Human cytomegalovirus (HCMV)
200,KEGG_MEDICUS_REFERENCE_CXCR4_GNB_G_RAC_SIGNALING_PATHWAY,N00433,Reference,Human immunodeficiency virus 1 (HIV-1)
201,KEGG_MEDICUS_REFERENCE_CXCR_GNB_G_ERK_SIGNALING_PATHWAY,N00152,Reference,CXCR signaling
202,KEGG_MEDICUS_REFERENCE_CXCR_GNB_G_PI3K_AKT_SIGNALING_PATHWAY,N00154,Reference,CXCR signaling
203,KEGG_MEDICUS_REFERENCE_CYTOKINE_JAK_STAT_SIGNALING_PATHWAY,N00053,Reference,Hepatocellular carcinoma
204,KEGG_MEDICUS_REFERENCE_DEPHOSPHORYLATION_OF_KINETOCHORE,N01536,Reference,Regulation of kinetochore-microtubule interactions
205,KEGG_MEDICUS_REFERENCE_DERMATAN_SULFATE_DEGRADATION,N00610,Reference,Glycosaminoglycan degradation
206,KEGG_MEDICUS_REFERENCE_DEUBIQUITINATION_OF_H2AK119,N01585,Reference,Epigenetic regulation by Polycomb complexes
207,KEGG_MEDICUS_REFERENCE_DISASSEMBLY_OF_MCC,N01533,Reference,Regulation of kinetochore-microtubule interactions
208,KEGG_MEDICUS_REFERENCE_DNA_DEGRADATION_BY_EXTRACELLULAR_ENDOLYSOSOMAL_DNASE,N01571,Reference,CGAS-STING signaling
209,KEGG_MEDICUS_REFERENCE_DNA_END_RESECTION_AND_RPA_LOADING,N01446,Reference,Double-strand break repair
210,KEGG_MEDICUS_REFERENCE_DNA_REPLICATION_LICENSING,N01468,Reference,DNA replication
211,KEGG_MEDICUS_REFERENCE_DNA_REPLICATION_TERMINATION,N01473,Reference,DNA replication
212,KEGG_MEDICUS_REFERENCE_DOUBLE_HOLLIDAY_JUNCTION_RESOLUTION,N01448,Reference,Double-strand break repair
213,KEGG_MEDICUS_REFERENCE_DOUBLE_STRAND_BREAK_SIGNALING,N01439,Reference,Double-strand break repair
214,KEGG_MEDICUS_REFERENCE_DRD1_GNAS_AC_PKA_SIGNALING_PATHWAY,N00410,Reference,Human cytomegalovirus (HCMV)
215,KEGG_MEDICUS_REFERENCE_DYNEIN_RECRUITMENT_TO_THE_KINETOCHORE,N01534,Reference,Regulation of kinetochore-microtubule interactions
216,KEGG_MEDICUS_REFERENCE_E2_ER_RAS_ERK_SIGNALING_PATHWAY,N01351,Reference,ERK signaling
217,KEGG_MEDICUS_REFERENCE_EARLY_ENDOSOMAL_FUSION,N01302,Reference,Membrane trafficking (bacteria)
218,KEGG_MEDICUS_REFERENCE_EGF_EGFR_ACTIN_SIGNALING_PATHWAY,N01078,Reference,Cytoskeletal regulation (viruses and bacteria)
219,KEGG_MEDICUS_REFERENCE_EGF_EGFR_PI3K_NFKB_SIGNALING_PATHWAY,N00390,Reference,PI3K signaling
220,KEGG_MEDICUS_REFERENCE_EGF_EGFR_PI3K_SIGNALING_PATHWAY,N00033,Reference,Colorectal cancer
221,KEGG_MEDICUS_REFERENCE_EGF_EGFR_PLCG_CALCINEURIN_SIGNALING_PATHWAY,N00147,Reference,Calcium signaling
222,KEGG_MEDICUS_REFERENCE_EGF_EGFR_PLCG_CAMK_SIGNALING_PATHWAY,N00026,Reference,Glioma
223,KEGG_MEDICUS_REFERENCE_EGF_EGFR_PLCG_ERK_SIGNALING_PATHWAY,N00023,Reference,Non-small cell lung cancer
224,KEGG_MEDICUS_REFERENCE_EGF_EGFR_RAS_ERK_SIGNALING_PATHWAY,N00001,Reference,Colorectal cancer
225,KEGG_MEDICUS_REFERENCE_EGF_EGFR_RAS_JNK_SIGNALING_PATHWAY,N00542,Reference,MAPK signaling
226,KEGG_MEDICUS_REFERENCE_EGF_EGFR_RAS_PI3K_SIGNALING_PATHWAY,N00030,Reference,Colorectal cancer
227,KEGG_MEDICUS_REFERENCE_EGF_EGFR_RAS_RALGDS_SIGNALING_PATHWAY,N00103,Reference,Colorectal cancer
228,KEGG_MEDICUS_REFERENCE_EGF_EGFR_RAS_RASSF1_SIGNALING_PATHWAY,N00096,Reference,Non-small cell lung cancer
229,KEGG_MEDICUS_REFERENCE_EGF_ERBB2_RAS_ERK_SIGNALING_PATHWAY,N00021,Reference,Gastric cancer
230,KEGG_MEDICUS_REFERENCE_EGF_JAK_STAT_SIGNALING_PATHWAY,N00094,Reference,Pancreatic cancer
231,KEGG_MEDICUS_REFERENCE_ELECTRON_TRANSFER_IN_COMPLEX_I,N00995,Reference,Alzheimer disease
232,KEGG_MEDICUS_REFERENCE_ELECTRON_TRANSFER_IN_COMPLEX_III,N00990,Reference,Mitochondrial ROS formation
233,KEGG_MEDICUS_REFERENCE_ELECTRON_TRANSFER_IN_COMPLEX_IV,N00998,Reference,Mitochondrial ROS formation
234,KEGG_MEDICUS_REFERENCE_EP_NE_ADRB_CAMP_SIGNALING_PATHWAY,N01345,Reference,cAMP signaling
235,KEGG_MEDICUS_REFERENCE_EP_NE_ADRB_PI3K_SIGNALING_PATHWAY,N01347,Reference,PI3K signaling
236,KEGG_MEDICUS_REFERENCE_EREG_EGFR_PI3K_SIGNALING_PATHWAY,N00282,Reference,Colorectal cancer
237,KEGG_MEDICUS_REFERENCE_EREG_EGFR_RAS_ERK_SIGNALING_PATHWAY,N00277,Reference,Colorectal cancer
238,KEGG_MEDICUS_REFERENCE_ERK_RSK_SIGNALING,N01601,Reference,MAPK signaling
239,KEGG_MEDICUS_REFERENCE_ESTABLISHMENT_OF_COHESION,N01484,Reference,Chromosome cohesion and segregation
240,KEGG_MEDICUS_REFERENCE_EXTRINSIC_APOPTOTIC_PATHWAY,N00145,Reference,TNF signaling
241,KEGG_MEDICUS_REFERENCE_FANCONI_ANEMIA_PATHWAY,N01464,Reference,Interstrand crosslink repair
242,KEGG_MEDICUS_REFERENCE_FAS_JNK_SIGNALING_PATHWAY,N01056,Reference,Apoptosis
243,KEGG_MEDICUS_REFERENCE_FE_TF_TRANSPORT,N01587,Reference,Ferroptosis
244,KEGG_MEDICUS_REFERENCE_FGF_FGFR_PI3K_SIGNALING_PATHWAY,N00037,Reference,Gastric cancer
245,KEGG_MEDICUS_REFERENCE_FGF_FGFR_RAS_ERK_SIGNALING_PATHWAY,N00019,Reference,Gastric cancer
246,KEGG_MEDICUS_REFERENCE_FLCN_MTORC1_SIGNALING_PATHWAY,N01584,Reference,mTOR signaling
247,KEGG_MEDICUS_REFERENCE_FLT3LG_FLT3_RAS_ERK_SIGNALING_PATHWAY,N00217,Reference,Acute myeloid leukemia
248,KEGG_MEDICUS_REFERENCE_FLT3LG_FLT3_RAS_PI3K_SIGNALING_PATHWAY,N00218,Reference,Pancreatic cancer
249,KEGG_MEDICUS_REFERENCE_FSHR_GNAS_PKA_SIGNALING_PATHWAY,N00922,Reference,KISS1-GnRH-LH/FSH-E2 signaling
250,KEGG_MEDICUS_REFERENCE_GATOR1_MTORC1_SIGNALING_PATHWAY,N01578,Reference,mTOR signaling
251,KEGG_MEDICUS_REFERENCE_GENE_SILENCING_BY_METHYLATION_OF_H3K27_AND_UBIQUITINATION_OF_H2AK119,N01577,Reference,Epigenetic regulation by Polycomb complexes
252,KEGG_MEDICUS_REFERENCE_GF_RTK_PI3K_SIGNALING_PATHWAY,N01656,Reference,PI3K signaling
253,KEGG_MEDICUS_REFERENCE_GF_RTK_RAS_ERK_SIGNALING_PATHWAY,N01592,Reference,MAPK signaling
254,KEGG_MEDICUS_REFERENCE_GF_RTK_RAS_PI3K_SIGNALING_PATHWAY,N01658,Reference,PI3K signaling
255,KEGG_MEDICUS_REFERENCE_GHRHR_PKA_GH_SIGNALING_PATHWAY,N00910,Reference,GHRH-GH-IGF signaling
256,KEGG_MEDICUS_REFERENCE_GH_JAK_STAT_SIGNALING_PATHWAY,N00907,Reference,GHRH-GH-IGF signaling
257,KEGG_MEDICUS_REFERENCE_GLOBAL_GENOME_NER,N01425,Reference,Nucleotide excision repair
258,KEGG_MEDICUS_REFERENCE_GLUCONEOGENESIS,N01605,Reference,Citrate cycle and pyruvate metabolism
259,KEGG_MEDICUS_REFERENCE_GLUTATHIONE_BIOSYNTHESIS,N01589,Reference,Glutathione biosynthesis
260,KEGG_MEDICUS_REFERENCE_GLYCOGEN_BIOSYNTHESIS,N00713,Reference,Glycogen metabolism
261,KEGG_MEDICUS_REFERENCE_GLYCOGEN_DEGRADATION,N00718,Reference,Glycogen metabolism
262,KEGG_MEDICUS_REFERENCE_GLYCOGEN_DEGRADATION_AMYLASE_,N00720,Reference,Glycogen metabolism
263,KEGG_MEDICUS_REFERENCE_GLYCOLYSIS,N00731,Reference,Glycogen metabolism
264,KEGG_MEDICUS_REFERENCE_GLYCOSAMINOGLYCAN_BIOSYNTHESIS_LINKAGE_TETRASACCHARIDE,N01574,Reference,Glycosaminoglycan biosynthesis
265,KEGG_MEDICUS_REFERENCE_GNRH_GNRHR_PLCB_PKC_SIGNALING_PATHWAY,N00873,Reference,KISS1-GnRH-LH/FSH-E2 signaling
266,KEGG_MEDICUS_REFERENCE_GPCR_PI3K_SIGNALING_PATHWAY,N01657,Reference,PI3K signaling
267,KEGG_MEDICUS_REFERENCE_GPCR_PLCB_ITPR_SIGNALING_PATHWAY,N01640,Reference,Calcium signaling
268,KEGG_MEDICUS_REFERENCE_GPI_ANCHOR_BIOSYNTHESIS,N00748,Reference,GPI-anchor biosynthesis
269,KEGG_MEDICUS_REFERENCE_HEDGEHOG_SIGNALING_PATHWAY,N00062,Reference,HH signaling
270,KEGG_MEDICUS_REFERENCE_HEDGEHOG_SIGNALING_PATHWAY_HH_LIGAND_SECRETION,N01537,Reference,HH signaling
271,KEGG_MEDICUS_REFERENCE_HEDGEHOG_SIGNALING_PATHWAY_PTCH_CORECEPTOR,N01538,Reference,HH signaling
272,KEGG_MEDICUS_REFERENCE_HEME_BIOSYNTHESIS,N00601,Reference,Heme biosynthesis
273,KEGG_MEDICUS_REFERENCE_HEPARAN_SULFATE_BIOSYNTHESIS,N01582,Reference,Glycosaminoglycan biosynthesis
274,KEGG_MEDICUS_REFERENCE_HEPARAN_SULFATE_DEGRADATION,N00615,Reference,Glycosaminoglycan degradation
275,KEGG_MEDICUS_REFERENCE_HGF_MET_PI3K_SIGNALING_PATHWAY,N00043,Reference,Gastric cancer
276,KEGG_MEDICUS_REFERENCE_HGF_MET_RAS_ERK_SIGNALING_PATHWAY,N00216,Reference,Gastric cancer
277,KEGG_MEDICUS_REFERENCE_HIF_1_SIGNALING_PATHWAY,N00079,Reference,Renal cell carcinoma
278,KEGG_MEDICUS_REFERENCE_HOMOLOGOUS_RECOMBINATION,N01452,Reference,Double-strand break repair
279,KEGG_MEDICUS_REFERENCE_HOMOLOGOUS_RECOMBINATION_IN_ICLR,N01466,Reference,Interstrand crosslink repair
280,KEGG_MEDICUS_REFERENCE_HORMONE_LIKE_CYTOKINE_TO_JAK_STAT_SIGNALING_PATHWAY,N01555,Reference,JAK-STAT signaling
281,KEGG_MEDICUS_REFERENCE_HYDROLYSIS_OF_SPHINGOMYELIN,N00649,Reference,Sphingolipid degradation
282,KEGG_MEDICUS_REFERENCE_ICOSLG_ICOS_PI3K_SIGNALING_PATHWAY,N01696,Reference,PI3K signaling
283,KEGG_MEDICUS_REFERENCE_IFN_RIPK1_3_SIGNALING_PATHWAY,N01662,Reference,Necroptosis
284,KEGG_MEDICUS_REFERENCE_IGF2_IGF1R_PI3K_SIGNALING_PATHWAY,N00234,Reference,Hepatocellular carcinoma
285,KEGG_MEDICUS_REFERENCE_IGF_IGF1R_PI3K_SIGNALING_PATHWAY,N00582,Reference,Herpes simplex virus 1 (HSV-1)
286,KEGG_MEDICUS_REFERENCE_IGF_IGF1R_RAS_ERK_SIGNALING_PATHWAY,N00233,Reference,GHRH-GH-IGF signaling
287,KEGG_MEDICUS_REFERENCE_IGF_IGFR_PI3K_NFKB_SIGNALING_PATHWAY,N00182,Reference,PI3K signaling
288,KEGG_MEDICUS_REFERENCE_IGG_FCGR_RAC_SIGNALING_PATHWAY,N01090,Reference,Cytoskeletal regulation (viruses and bacteria)
289,KEGG_MEDICUS_REFERENCE_II_BLOOD_GROUP_ANTIGEN_BIOSYNTHESIS,N01678,Reference,Blood group carbohydrate antigen biosynthesis
290,KEGG_MEDICUS_REFERENCE_IL10_FAMILY_TO_JAK_STAT_SIGNALING_PATHWAY,N00415,Reference,JAK-STAT signaling
291,KEGG_MEDICUS_REFERENCE_IL12_23_TO_JAK_STAT_SIGNALING_PATHWAY,N01557,Reference,JAK-STAT signaling
292,KEGG_MEDICUS_REFERENCE_IL1_IL1R_JNK_SIGNALING_PATHWAY,N00188,Reference,MAPK signaling
293,KEGG_MEDICUS_REFERENCE_IL1_IL1R_P38_SIGNALING_PATHWAY,N00186,Reference,MAPK signaling
294,KEGG_MEDICUS_REFERENCE_IL2_FAMILY_TO_JAK_STAT_SIGNALING_PATHWAY,N01554,Reference,JAK-STAT signaling
295,KEGG_MEDICUS_REFERENCE_IL6_FAMILY_TO_JAK_STAT_SIGNALING_PATHWAY,N01556,Reference,JAK-STAT signaling
296,KEGG_MEDICUS_REFERENCE_INACTIVATION_OF_CONDENSIN_I,N01501,Reference,Chromosome cohesion and segregation
297,KEGG_MEDICUS_REFERENCE_INTRINSIC_APOPTOTIC_PATHWAY,N00098,Reference,Apoptosis
298,KEGG_MEDICUS_REFERENCE_IRE1A_JNK_SIGNALING_PATHWAY,N01013,Reference,Unfolded protein response
299,KEGG_MEDICUS_REFERENCE_ISOLEUCINE_DEGRADATION,N00856,Reference,"Valine,leucine and isoleucine degradation"
300,KEGG_MEDICUS_REFERENCE_ITGA_B_FAK_CDC42_SIGNALING_PATHWAY,N01070,Reference,Cytoskeletal regulation (viruses and bacteria)
301,KEGG_MEDICUS_REFERENCE_ITGA_B_FAK_RAC_SIGNALING_PATHWAY,N01068,Reference,Cytoskeletal regulation (viruses and bacteria)
302,KEGG_MEDICUS_REFERENCE_ITGA_B_RHOGAP_RHOA_SIGNALING_PATHWAY,N00393,Reference,Human cytomegalovirus (HCMV)
303,KEGG_MEDICUS_REFERENCE_ITGA_B_RHOGEF_RHOA_SIGNALING_PATHWAY,N01072,Reference,Cytoskeletal regulation (viruses and bacteria)
304,KEGG_MEDICUS_REFERENCE_ITGA_B_RHOG_RAC_SIGNALING_PATHWAY,N00951,Reference,Cytoskeletal regulation (viruses and bacteria)
305,KEGG_MEDICUS_REFERENCE_ITGA_B_TALIN_VINCULIN_SIGNALING_PATHWAY,N01080,Reference,Cytoskeletal regulation (viruses and bacteria)
306,KEGG_MEDICUS_REFERENCE_KEAP1_NRF2_SIGNALING_PATHWAY,N00243,Reference,Hepatocellular carcinoma
307,KEGG_MEDICUS_REFERENCE_KERATAN_SULFATE_DEGRADATION,N00623,Reference,Glycosaminoglycan degradation
308,KEGG_MEDICUS_REFERENCE_KINETOCHORE_FIBER_ORGANIZATION,N01547,Reference,Regulation of kinetochore-microtubule interactions
309,KEGG_MEDICUS_REFERENCE_KINETOCHORE_MICROTUBULE_ATTACHMENT,N01535,Reference,Regulation of kinetochore-microtubule interactions
310,KEGG_MEDICUS_REFERENCE_KISS1_KISS1R_PLCB_PKC_SIGNALING_PATHWAY,N00869,Reference,KISS1-GnRH-LH/FSH-E2 signaling
311,KEGG_MEDICUS_REFERENCE_KITLG_KIT_PI3K_SIGNALING_PATHWAY,N00045,Reference,Acute myeloid leukemia
312,KEGG_MEDICUS_REFERENCE_KITLG_KIT_RAS_ERK_SIGNALING_PATHWAY,N00215,Reference,Acute myeloid leukemia
313,KEGG_MEDICUS_REFERENCE_LECTIN_PATHWAY_OF_COAGULATION_CASCADE_FIBRINOGEN_TO_FIBRIN,N01502,Reference,SARS coronavirus 2 (SARS-CoV-2)
314,KEGG_MEDICUS_REFERENCE_LECTIN_PATHWAY_OF_COAGULATION_CASCADE_PROTHROMBIN_TO_THROMBIN,N01315,Reference,SARS coronavirus 2 (SARS-CoV-2)
315,KEGG_MEDICUS_REFERENCE_LECTIN_PATHWAY_OF_COMPLEMENT_CASCADE_C4_C2_TO_C3_CONVERTASE_FORMATION,N01491,Reference,Complement cascade
316,KEGG_MEDICUS_REFERENCE_LESION_BYPASS_BY_TLS_AND_DSB_FORMATION,N01465,Reference,Interstrand crosslink repair
317,KEGG_MEDICUS_REFERENCE_LEUCINE_DEGRADATION,N00851,Reference,"Valine,leucine and isoleucine degradation"
318,KEGG_MEDICUS_REFERENCE_LEWIS_X_ANTIGEN_BIOSYNTHESIS,N01672,Reference,Blood group carbohydrate antigen biosynthesis
319,KEGG_MEDICUS_REFERENCE_LHCGR_GNAS_PKA_SIGNALING_PATHWAY,N00885,Reference,KISS1-GnRH-LH/FSH-E2 signaling
320,KEGG_MEDICUS_REFERENCE_LIGHT_HVEM_NFKB_SIGNALING_PATHWAY,N00559,Reference,TNF signaling
321,KEGG_MEDICUS_REFERENCE_LOADING_OF_THE_SMC5_SMC6_COMPLEX,N01636,Reference,Double-strand break repair
322,KEGG_MEDICUS_REFERENCE_LONG_PATCH_BER,N01436,Reference,Base excision repair
323,KEGG_MEDICUS_REFERENCE_LPAR_GNB_G_RHO_SIGNALING_PATHWAY,N00408,Reference,Human cytomegalovirus (HCMV)
324,KEGG_MEDICUS_REFERENCE_LPA_GNA12_13_RHOA_SIGNALING_PATHWAY,N01097,Reference,Cytoskeletal regulation (viruses and bacteria)
325,KEGG_MEDICUS_REFERENCE_LPA_GNAQ_11_RHOA_SIGNALING_PATHWAY,N01104,Reference,Cytoskeletal regulation (viruses and bacteria)
326,KEGG_MEDICUS_REFERENCE_LYSOSOMAL_CA2_RELEASE,N01644,Reference,Calcium signaling
327,KEGG_MEDICUS_REFERENCE_MACHR_CA2_APOPTOTIC_PATHWAY,N01000,Reference,Calcium signaling
328,KEGG_MEDICUS_REFERENCE_MAGI_PTEN_SIGNALING_PATHWAY,N00342,Reference,Human papillomavirus (HPV)
329,KEGG_MEDICUS_REFERENCE_MANNOSE_TYPE_O_GLYCAN_BIOSYNTHESIS_FKTN_TO_LARGE,N00699,Reference,O-Glycan biosynthesis
330,KEGG_MEDICUS_REFERENCE_MANNOSE_TYPE_O_GLYCAN_BIOSYNTHESIS_POMT_TO_POMK,N00627,Reference,O-Glycan biosynthesis
331,KEGG_MEDICUS_REFERENCE_MDA5_IRF7_3_SIGNALING_PATHWAY,N01308,Reference,RLR signaling
332,KEGG_MEDICUS_REFERENCE_MDM2_P21_CELL_CYCLE_G1_S_N00066,N00066,Reference,Hepatocellular carcinoma
333,KEGG_MEDICUS_REFERENCE_MDM2_P21_CELL_CYCLE_G1_S_N00536,N00536,Reference,Hepatocellular carcinoma
334,KEGG_MEDICUS_REFERENCE_MEMBRANE_INITIATED_PROGESTERONE_SIGNALING_PATHWAY,N01356,Reference,PI3K signaling
335,KEGG_MEDICUS_REFERENCE_METHIONINE_DEGRADATION,N01607,Reference,Methionine metabolism
336,KEGG_MEDICUS_REFERENCE_MEVALONATE_PATHWAY,N01635,Reference,Cholesterol biosynthesis
337,KEGG_MEDICUS_REFERENCE_MGLUR1_TRPC3_SIGNALING_PATHWAY,N00953,Reference,Calcium signaling
338,KEGG_MEDICUS_REFERENCE_MGLUR5_CA2_APOPTOTIC_PATHWAY,N00984,Reference,Calcium signaling
339,KEGG_MEDICUS_REFERENCE_MICROTUBULE_DEPOLYMERIZATION,N01561,Reference,Regulation of kinetochore-microtubule interactions
340,KEGG_MEDICUS_REFERENCE_MICROTUBULE_DEPOLYMERIZATION_AT_THE_MINUS_ENDS,N01562,Reference,Regulation of kinetochore-microtubule interactions
341,KEGG_MEDICUS_REFERENCE_MICROTUBULE_NUCLEATION,N01544,Reference,Regulation of kinetochore-microtubule interactions
342,KEGG_MEDICUS_REFERENCE_MICROTUBULE_RHOA_SIGNALING_PATHWAY,N01285,Reference,Cytoskeletal regulation (viruses and bacteria)
343,KEGG_MEDICUS_REFERENCE_MISMATCH_REPAIR,N01432,Reference,Mismatch repair
344,KEGG_MEDICUS_REFERENCE_MITOCHONDRIAL_COMPLEX_UCP1_IN_THERMOGENESIS,N01691,Reference,Thermogenesis
345,KEGG_MEDICUS_REFERENCE_MLK_JNK_SIGNALING_PATHWAY,N01594,Reference,MAPK signaling
346,KEGG_MEDICUS_REFERENCE_MODIFYING_OF_CONDENSIN_II_SUBUNITS,N01499,Reference,Chromosome cohesion and segregation
347,KEGG_MEDICUS_REFERENCE_MYOSTATIN_SIGNALING_PATHWAY,N01457,Reference,TGFB signaling
348,KEGG_MEDICUS_REFERENCE_NAD_BIOSYNTHESIS,N01723,Reference,Lysine degradation
349,KEGG_MEDICUS_REFERENCE_NLRP3_INFLAMMASOME_SIGNALING_PATHWAY,N00742,Reference,NLR signaling
350,KEGG_MEDICUS_REFERENCE_NODAL_SIGNALING_PATHWAY,N01459,Reference,TGFB signaling
351,KEGG_MEDICUS_REFERENCE_NOD_NFKB_SIGNALING_PATHWAY,N00940,Reference,NLR signaling
352,KEGG_MEDICUS_REFERENCE_NON_CANONICAL_INFLAMMASOME_SIGNALING_PATHWAY,N00934,Reference,NLR signaling
353,KEGG_MEDICUS_REFERENCE_NON_HOMOLOGOUS_END_JOINING,N01445,Reference,Double-strand break repair
354,KEGG_MEDICUS_REFERENCE_NOTCH_LIGAND_UBIQUITYLATION,N01479,Reference,NOTCH signaling
355,KEGG_MEDICUS_REFERENCE_NOTCH_MESP2_SIGNALING,N01481,Reference,NOTCH signaling
356,KEGG_MEDICUS_REFERENCE_NOTCH_PROTEOLYTIC_ACTIVATION,N01478,Reference,NOTCH signaling
357,KEGG_MEDICUS_REFERENCE_NOTCH_SIGNALING_PATHWAY,N00086,Reference,NOTCH signaling
358,KEGG_MEDICUS_REFERENCE_NRG_ERBB4_PI3K_SIGNALING_PATHWAY,N01163,Reference,PI3K signaling
359,KEGG_MEDICUS_REFERENCE_NUCLEAR_EXPORT_OF_MRNA,N01152,Reference,Amyotrophic lateral sclerosis
360,KEGG_MEDICUS_REFERENCE_NUCLEAR_INITIATED_ESTROGEN_SIGNALING_PATHWAY,N00286,Reference,KISS1-GnRH-LH/FSH-E2 signaling
361,KEGG_MEDICUS_REFERENCE_N_GLYCAN_BIOSYNTHESIS,N00820,Reference,N-Glycan biosynthesis
362,KEGG_MEDICUS_REFERENCE_N_GLYCAN_PRECURSOR_BIOSYNTHESIS_ALG6_TO_OST,N00681,Reference,N-Glycan biosynthesis
363,KEGG_MEDICUS_REFERENCE_N_GLYCAN_PRECURSOR_BIOSYNTHESIS_ALG7_TO_ALG11,N00653,Reference,N-Glycan biosynthesis
364,KEGG_MEDICUS_REFERENCE_N_GLYCAN_PRECURSOR_BIOSYNTHESIS_GLC_6P_TO_MAN_P_DOL,N00667,Reference,N-Glycan biosynthesis
365,KEGG_MEDICUS_REFERENCE_OKAZAKI_FRAGMENT_MATURATION,N01472,Reference,DNA replication
366,KEGG_MEDICUS_REFERENCE_ORGANIZATION_OF_THE_INNER_KINETOCHORE,N01525,Reference,Regulation of kinetochore-microtubule interactions
367,KEGG_MEDICUS_REFERENCE_ORGANIZATION_OF_THE_OUTER_KINETOCHORE,N01526,Reference,Regulation of kinetochore-microtubule interactions
368,KEGG_MEDICUS_REFERENCE_ORIGIN_UNWINDING_AND_ELONGATION,N01471,Reference,DNA replication
369,KEGG_MEDICUS_REFERENCE_P16_CELL_CYCLE_G1_S,N00069,Reference,Pancreatic cancer
370,KEGG_MEDICUS_REFERENCE_P27_CELL_CYCLE_G1_S,N00091,Reference,Gastric cancer
371,KEGG_MEDICUS_REFERENCE_P300_P21_CELL_CYCLE_G1_S,N00347,Reference,Human papillomavirus (HPV)
372,KEGG_MEDICUS_REFERENCE_P4_PR_PI3K_SIGNALING_PATHWAY,N01358,Reference,PI3K signaling
373,KEGG_MEDICUS_REFERENCE_P4_PR_RAS_ERK_SIGNALING_PATHWAY,N01360,Reference,ERK signaling
374,KEGG_MEDICUS_REFERENCE_PDGF_PDGFR_PI3K_SIGNALING_PATHWAY,N00039,Reference,Glioma
375,KEGG_MEDICUS_REFERENCE_PDGF_PDGFR_PLCG_CAMK_SIGNALING_PATHWAY,N00028,Reference,Glioma
376,KEGG_MEDICUS_REFERENCE_PDGF_PDGFR_RAS_ERK_SIGNALING_PATHWAY,N00015,Reference,Glioma
377,KEGG_MEDICUS_REFERENCE_PDL_PD1_SHP_PI3K_SIGNALING_PATHWAY,N01165,Reference,PI3K signaling
378,KEGG_MEDICUS_REFERENCE_PINK_PARKIN_MEDIATED_AUTOPHAGOSOME_FORMATION,N01137,Reference,Amyotrophic lateral sclerosis
379,KEGG_MEDICUS_REFERENCE_PKA_HOLOENZYME,N01542,Reference,CRH-ACTH-cortisol signaling
380,KEGG_MEDICUS_REFERENCE_PKR_EIF2ALPHA_SIGNALING_PATHWAY,N00571,Reference,Influenza A virus (IAV)
381,KEGG_MEDICUS_REFERENCE_PLASMIN_MEDIATED_ACTIVATION_OF_LATENT_TGF_BETA,N01460,Reference,TGFB signaling
382,KEGG_MEDICUS_REFERENCE_PP2A_AKT_SIGNALING_PATHWAY,N00355,Reference,PI3K signaling
383,KEGG_MEDICUS_REFERENCE_PRE_IC_FORMATION,N01470,Reference,DNA replication
384,KEGG_MEDICUS_REFERENCE_PRNP_PI3K_NOX2_SIGNALING_PATHWAY,N01204,Reference,Prion disease
385,KEGG_MEDICUS_REFERENCE_PROK_PRKR_GI_ERK_SIGNALING_PATHWAY,N00879,Reference,Hypogonadotropic hypogonadism
386,KEGG_MEDICUS_REFERENCE_PROMOTION_OF_MICROTUBULE_GROWTH,N01553,Reference,Regulation of kinetochore-microtubule interactions
387,KEGG_MEDICUS_REFERENCE_PTH_PTH1R_PKA_SIGNALING_PATHWAY,N00288,Reference,CaSR-PTH signaling
388,KEGG_MEDICUS_REFERENCE_PURINE_SALVAGE_PATHWAY_ADENINE_TO_AMP,N01418,Reference,Purine salvage pathway
389,KEGG_MEDICUS_REFERENCE_PURINE_SALVAGE_PATHWAY_HYPOXANTHINE_GUANINE_TO_IMP_GMP,N01421,Reference,Purine salvage pathway
390,KEGG_MEDICUS_REFERENCE_RAB7_REGULATED_MICROTUBULE_MINUS_END_DIRECTED_TRANSPORT,N01295,Reference,Membrane trafficking (bacteria)
391,KEGG_MEDICUS_REFERENCE_RAC_CDC42_PAK_ERK_SIGNALING_PATHWAY,N01119,Reference,MAPK signaling
392,KEGG_MEDICUS_REFERENCE_RAD51_DSDNA_DESTABILIZATION,N01539,Reference,Interstrand crosslink repair
393,KEGG_MEDICUS_REFERENCE_RECRUITMENT_AND_FORMATION_OF_THE_MCC,N01529,Reference,Regulation of kinetochore-microtubule interactions
394,KEGG_MEDICUS_REFERENCE_REGULATION_OF_COMPLEMENT_CASCADE_CFHR,N01504,Reference,Complement cascade
395,KEGG_MEDICUS_REFERENCE_REGULATION_OF_COMPLEMENT_CASCADE_MAC_INHIBITION,N01505,Reference,Complement cascade
396,KEGG_MEDICUS_REFERENCE_REGULATION_OF_FIBRINOLYTIC_SYSTEM_C1INH,N01520,Reference,Complement cascade
397,KEGG_MEDICUS_REFERENCE_REGULATION_OF_FIBRINOLYTIC_SYSTEM_PAI,N01524,Reference,Coagulation cascade
398,KEGG_MEDICUS_REFERENCE_REGULATION_OF_GF_RTK_RAS_ERK_SIGNALING_MRAS_SHOC2_PP1_HOLOPHOSPHATASE,N01598,Reference,MAPK signaling
399,KEGG_MEDICUS_REFERENCE_REGULATION_OF_GF_RTK_RAS_ERK_SIGNALING_PATHWAY_ADAPTOR_PROTEINS,N01595,Reference,MAPK signaling
400,KEGG_MEDICUS_REFERENCE_REGULATION_OF_GF_RTK_RAS_ERK_SIGNALING_PTP,N01593,Reference,MAPK signaling
401,KEGG_MEDICUS_REFERENCE_REGULATION_OF_GF_RTK_RAS_ERK_SIGNALING_RASGAP,N01600,Reference,MAPK signaling
402,KEGG_MEDICUS_REFERENCE_REGULATION_OF_GF_RTK_RAS_ERK_SIGNALING_RAS_UBIQUITINATION_BY_CUL3_COMPLEX,N01596,Reference,MAPK signaling
403,KEGG_MEDICUS_REFERENCE_REGULATION_OF_GF_RTK_RAS_ERK_SIGNALING_SPRED_AND_NF1,N01597,Reference,MAPK signaling
404,KEGG_MEDICUS_REFERENCE_REGULATION_OF_GF_RTK_RAS_ERK_SIGNALING_UBIQUITINATION_OF_RTK_BY_CBL,N01599,Reference,MAPK signaling
405,KEGG_MEDICUS_REFERENCE_REGULATION_OF_SERCA,N01646,Reference,Calcium signaling
406,KEGG_MEDICUS_REFERENCE_REGULATION_OF_TNF_NFKB_SIGNALING_PATHWAY_LUBAC_MEDIATED_LINEAR_UBIQUITINATION,N01545,Reference,TNF signaling
407,KEGG_MEDICUS_REFERENCE_RELN_VLDLR_PI3K_SIGNALING_PATHWAY,N00963,Reference,Spinocerebellar ataxia
408,KEGG_MEDICUS_REFERENCE_RENIN_ANGIOTENSIN_SIGNALING_PATHWAY,N01743,Reference,Renin-angiotensin-aldosterone signaling
409,KEGG_MEDICUS_REFERENCE_RETROGRADE_AXONAL_TRANSPORT,N00976,Reference,Parkinson disease
410,KEGG_MEDICUS_REFERENCE_RIG_I_IRF7_3_SIGNALING_PATHWAY,N00469,Reference,RLR signaling
411,KEGG_MEDICUS_REFERENCE_RIG_I_NFKB_SIGNALING_PATHWAY,N00688,Reference,RLR signaling
412,KEGG_MEDICUS_REFERENCE_RTK_PLCG_ITPR_SIGNALING_PATHWAY,N01641,Reference,Calcium signaling
413,KEGG_MEDICUS_REFERENCE_SEROTONIN_METABOLISM,N01551,Reference,Dopamine and serotonin metabolism
414,KEGG_MEDICUS_REFERENCE_SIALYL_LEWIS_X_ANTIGEN_BIOSYNTHESIS,N01674,Reference,Blood group carbohydrate antigen biosynthesis
415,KEGG_MEDICUS_REFERENCE_SKELETAL_TYPE_VGCC_RYR_SIGNALING,N01638,Reference,Calcium signaling
416,KEGG_MEDICUS_REFERENCE_SPINDLE_ASSEMBLY_CHECKPOINT_SIGNALING,N00493,Reference,Cell cycle
417,KEGG_MEDICUS_REFERENCE_STEROID_HORMONE_BIOSYNTHESIS_PROGESTERONE_TO_CORTISOL_CORTISONE,N00338,Reference,Steroid hormone biosynthesis
418,KEGG_MEDICUS_REFERENCE_STRAD_STK11_TSC_SIGNALING_PATHWAY,N01576,Reference,mTOR signaling
419,KEGG_MEDICUS_REFERENCE_TAC3_TACR3_PLC_PKC_SIGNALING_PATHWAY,N00882,Reference,KISS1-GnRH-LH/FSH-E2 signaling
420,KEGG_MEDICUS_REFERENCE_TBK1_MEDIATED_AUTOPHAGOSOME_FORMATION,N01140,Reference,Amyotrophic lateral sclerosis
421,KEGG_MEDICUS_REFERENCE_TCR_PLCG_ITPR_SIGNALING_PATHWAY,N01106,Reference,Calcium signaling
422,KEGG_MEDICUS_REFERENCE_TELOMERE_ELONGATION,N01477,Reference,Telomere length regulation
423,KEGG_MEDICUS_REFERENCE_TESTOSTERONE_BIOSYNTHESIS,N01541,Reference,Steroid hormone biosynthesis
424,KEGG_MEDICUS_REFERENCE_TETHERING_OF_LATE_ENDOSOMES_AND_LYSOSOMES,N01300,Reference,Membrane trafficking (bacteria)
425,KEGG_MEDICUS_REFERENCE_TGFA_EGFR_PI3K_SIGNALING_PATHWAY,N00231,Reference,Colorectal cancer
426,KEGG_MEDICUS_REFERENCE_TGFA_EGFR_PLCG_PKC_SIGNALING_PATHWAY,N00227,Reference,Hepatocellular carcinoma
427,KEGG_MEDICUS_REFERENCE_TGFA_EGFR_RAS_ERK_SIGNALING_PATHWAY,N00229,Reference,Colorectal cancer
428,KEGG_MEDICUS_REFERENCE_TGF_BETA_SIGNALING_PATHWAY,N00063,Reference,TGFB signaling
429,KEGG_MEDICUS_REFERENCE_THYROID_HORMONE_SIGNALING_PATHWAY,N00798,Reference,TRH-TSH-TH signaling
430,KEGG_MEDICUS_REFERENCE_TIGHT_JUNCTION_ACTIN_SIGNALING_PATHWAY,N01287,Reference,Cytoskeletal regulation (viruses and bacteria)
431,KEGG_MEDICUS_REFERENCE_TLR1_2_4_NFKB_SIGNALING_PATHWAY,N00435,Reference,TLR signaling
432,KEGG_MEDICUS_REFERENCE_TLR2_4_MAPK_SIGNALING_PATHWAY,N00438,Reference,TLR signaling
433,KEGG_MEDICUS_REFERENCE_TLR3_IRF3_SIGNALING_PATHWAY,N00149,Reference,TLR signaling
434,KEGG_MEDICUS_REFERENCE_TLR3_IRF7_SIGNALING_PATHWAY,N00148,Reference,TLR signaling
435,KEGG_MEDICUS_REFERENCE_TLR3_NFKB_SIGNALING_PATHWAY,N00563,Reference,Herpes simplex virus 1 (HSV-1)
436,KEGG_MEDICUS_REFERENCE_TLR4_IRF3_7_SIGNALING_PATHWAY,N00553,Reference,TLR signaling
437,KEGG_MEDICUS_REFERENCE_TLR5_NFKB_SIGNALING_PATHWAY,N01566,Reference,TLR signaling
438,KEGG_MEDICUS_REFERENCE_TLR7_8_9_IRF5_SIGNALING_PATHWAY,N01543,Reference,TLR signaling
439,KEGG_MEDICUS_REFERENCE_TLR7_9_IRF7_SIGNALING_PATHWAY,N00690,Reference,TLR signaling
440,KEGG_MEDICUS_REFERENCE_TNF_JNK_SIGNALING_PATHWAY,N00446,Reference,TNF signaling
441,KEGG_MEDICUS_REFERENCE_TNF_NFKB_SIGNALING_PATHWAY,N00151,Reference,TNF signaling
442,KEGG_MEDICUS_REFERENCE_TNF_P38_SIGNALING_PATHWAY,N00444,Reference,TNF signaling
443,KEGG_MEDICUS_REFERENCE_TNF_RIPK1_3_SIGNALING_PATHWAY,N01621,Reference,Necroptosis
444,KEGG_MEDICUS_REFERENCE_TRAIP_DEPENDENT_REPLISOME_DISASSEMBLY,N01474,Reference,DNA replication
445,KEGG_MEDICUS_REFERENCE_TRANSCRIPTIONAL_ACTIVATION_BY_ACETYLATION_OF_H3K27,N01701,Reference,Epigenetic regulation by Polycomb complexes
446,KEGG_MEDICUS_REFERENCE_TRANSCRIPTION_COUPLED_NER,N01430,Reference,Nucleotide excision repair
447,KEGG_MEDICUS_REFERENCE_TRANSLATION_INITIATION,N01317,Reference,SARS coronavirus 2 (SARS-CoV-2)
448,KEGG_MEDICUS_REFERENCE_TRANSPORT_OF_CALCIUM,N00970,Reference,Alzheimer disease
449,KEGG_MEDICUS_REFERENCE_TRAPPI_RAB1_SIGNALING_PATHWAY,N01291,Reference,Membrane trafficking (bacteria)
450,KEGG_MEDICUS_REFERENCE_TRH_TRHR_PLCB_PKC_SIGNALING_PATHWAY,N00918,Reference,TRH-TSH-TH signaling
451,KEGG_MEDICUS_REFERENCE_TSC1_2_MTORC1_SIGNALING_PATHWAY,N01575,Reference,mTOR signaling
452,KEGG_MEDICUS_REFERENCE_TSH_DUOX2_TG_SIGNALING_PATHWAY,N00793,Reference,TRH-TSH-TH signaling
453,KEGG_MEDICUS_REFERENCE_TSH_TG_SIGNALING_PATHWAY,N00782,Reference,TRH-TSH-TH signaling
454,KEGG_MEDICUS_REFERENCE_TYPE_II_INTERFERON_TO_JAK_STAT_SIGNALING_PATHWAY,N01559,Reference,JAK-STAT signaling
455,KEGG_MEDICUS_REFERENCE_TYPE_I_IFN_SIGNALING_PATHWAY,N00150,Reference,Hepatocellular carcinoma
456,KEGG_MEDICUS_REFERENCE_TYPE_I_INTERFERON_TO_JAK_STAT_SIGNALING_PATHWAY,N01558,Reference,JAK-STAT signaling
457,KEGG_MEDICUS_REFERENCE_TYROSINE_DEGRADATION,N00708,Reference,Phenylalanine and tyrosine metabolism
458,KEGG_MEDICUS_REFERENCE_UREA_CYCLE,N00593,Reference,Urea cycle
459,KEGG_MEDICUS_REFERENCE_VALINE_DEGRADATION,N00852,Reference,"Valine,leucine and isoleucine degradation"
460,KEGG_MEDICUS_REFERENCE_VGCC_CA2_APOPTOTIC_PATHWAY,N00967,Reference,Alzheimer disease
461,KEGG_MEDICUS_REFERENCE_V_D_J_RECOMBINATION,N01467,Reference,Double-strand break repair
462,KEGG_MEDICUS_REFERENCE_WEE1_CELL_CYCLE_G2_M,N00459,Reference,Human immunodeficiency virus 1 (HIV-1)
463,KEGG_MEDICUS_REFERENCE_WNT5A_ROR_SIGNALING_PATHWAY,N01427,Reference,WNT signaling
464,KEGG_MEDICUS_REFERENCE_WNT_SIGNALING_MODULATION_LGR_RSPO,N01440,Reference,WNT signaling
465,KEGG_MEDICUS_REFERENCE_WNT_SIGNALING_MODULATION_SOST_LRP4,N01441,Reference,WNT signaling
466,KEGG_MEDICUS_REFERENCE_WNT_SIGNALING_MODULATION_WNT_ACYLATION,N01443,Reference,WNT signaling
467,KEGG_MEDICUS_REFERENCE_WNT_SIGNALING_MODULATION_WNT_INHIBITOR,N01442,Reference,WNT signaling
468,KEGG_MEDICUS_REFERENCE_WNT_SIGNALING_PATHWAY,N00056,Reference,WNT signaling
469,KEGG_MEDICUS_VARIANT_AMPLIFIED_CCND1_TO_CELL_CYCLE_G1_S,N00275,Variant,Breast cancer
470,KEGG_MEDICUS_VARIANT_AMPLIFIED_CCNE_TO_CELL_CYCLE_G1_S,N00255,Variant,Gastric cancer
471,KEGG_MEDICUS_VARIANT_AMPLIFIED_CDK4_TO_CELL_CYCLE_G1_S,N00072,Variant,Glioma
472,KEGG_MEDICUS_VARIANT_AMPLIFIED_EGFR_TO_PI3K_SIGNALING_PATHWAY,N00035,Variant,Glioma
473,KEGG_MEDICUS_VARIANT_AMPLIFIED_EGFR_TO_PLCG_CAMK_SIGNALING_PATHWAY,N00027,Variant,Glioma
474,KEGG_MEDICUS_VARIANT_AMPLIFIED_EGFR_TO_RAS_ERK_SIGNALING_PATHWAY,N00006,Variant,Bladder cancer
475,KEGG_MEDICUS_VARIANT_AMPLIFIED_FGFR_TO_PI3K_SIGNALING_PATHWAY,N00038,Variant,Gastric cancer
476,KEGG_MEDICUS_VARIANT_AMPLIFIED_FGFR_TO_RAS_ERK_SIGNALING_PATHWAY,N00020,Variant,Gastric cancer
477,KEGG_MEDICUS_VARIANT_AMPLIFIED_MDM2_TO_P21_CELL_CYCLE_G1_S,N00068,Variant,Glioma
478,KEGG_MEDICUS_VARIANT_AMPLIFIED_MET_TO_PI3K_SIGNALING_PATHWAY,N00260,Variant,Gastric cancer
479,KEGG_MEDICUS_VARIANT_AMPLIFIED_MYCN_TO_TRANSCRIPTIONAL_ACTIVATION,N00131,Variant,Transcription
480,KEGG_MEDICUS_VARIANT_AMPLIFIED_MYCN_TO_TRANSCRIPTIONAL_REPRESSION,N00132,Variant,Transcription
481,KEGG_MEDICUS_VARIANT_AMPLIFIED_MYC_TO_CELL_CYCLE_G1_S,N00089,Variant,Small cell lung cancer
482,KEGG_MEDICUS_VARIANT_AMPLIFIED_MYC_TO_P15_CELL_CYCLE_G1_S,N00088,Variant,Small cell lung cancer
483,KEGG_MEDICUS_VARIANT_AMPLIFIED_MYC_TO_P27_CELL_CYCLE_G1_S,N00092,Variant,Small cell lung cancer
484,KEGG_MEDICUS_VARIANT_AMPLIFIED_PDGFR_TO_PI3K_SIGNALING_PATHWAY,N00040,Variant,Glioma
485,KEGG_MEDICUS_VARIANT_AMPLIFIED_PDGFR_TO_PLCG_CAMK_SIGNALING_PATHWAY,N00029,Variant,Glioma
486,KEGG_MEDICUS_VARIANT_AMPLIFIED_PDGFR_TO_RAS_ERK_SIGNALING_PATHWAY,N00018,Variant,Glioma
487,KEGG_MEDICUS_VARIANT_AMPLIFIED_REL_TO_TRANSCRIPTION,N00123,Variant,Transcription
488,KEGG_MEDICUS_VARIANT_AREG_OVEREXPRESSION_TO_PI3K_SIGNALING_PATHWAY,N00285,Variant,Colorectal cancer
489,KEGG_MEDICUS_VARIANT_BCL2_OVEREXPRESSION_TO_INTRINSIC_APOPTOTIC_PATHWAY,N00100,Variant,Small cell lung cancer
490,KEGG_MEDICUS_VARIANT_BCR_ABL_FUSION_KINASE_TO_PI3K_SIGNALING_PATHWAY,N00048,Variant,Chronic myeloid leukemia
491,KEGG_MEDICUS_VARIANT_BCR_ABL_FUSION_KINASE_TO_RAS_ERK_SIGNALING_PATHWAY,N00002,Variant,Chronic myeloid leukemia
492,KEGG_MEDICUS_VARIANT_CDH1_REDUCED_EXPRESSION_TO_BETA_CATENIN_SIGNALING_PATHWAY,N00061,Variant,Thyroid cancer
493,KEGG_MEDICUS_VARIANT_CYP11B1_CYP11B2_FUSION_TO_ACTH_CORTISOL_SIGNALING_PATHWAY,N00298,Variant,CRH-ACTH-cortisol signaling
494,KEGG_MEDICUS_VARIANT_DAB1_OVEREXPRESSION_TO_RELN_VLDLR_PI3K_SIGNALING_PATHWAY,N00964,Variant,Spinocerebellar ataxia
495,KEGG_MEDICUS_VARIANT_DELETED_DMD_TO_DYSTROPHIN_ASSOCIATED_PROTEIN_COMPLEX,N00465,Variant,
496,KEGG_MEDICUS_VARIANT_DUPLICATION_OR_MUTATION_ACTIVATED_FLT3_TO_RAS_ERK_SIGNALING_PATHWAY,N00004,Variant,Acute myeloid leukemia
497,KEGG_MEDICUS_VARIANT_DUPLICATION_OR_MUTATION_ACTIVATED_FLT3_TO_RAS_PI3K_SIGNALING_PATHWAY,N00031,Variant,Acute myeloid leukemia
498,KEGG_MEDICUS_VARIANT_EGFR_OVEREXPRESSION_TO_PI3K_SIGNALING_PATHWAY,N00042,Variant,Colorectal cancer
499,KEGG_MEDICUS_VARIANT_EGF_OVEREXPRESSION_TO_PI3K_SIGNALING_PATHWAY,N00281,Variant,Colorectal cancer
500,KEGG_MEDICUS_VARIANT_EGF_OVEREXPRESSION_TO_RAS_ERK_SIGNALING_PATHWAY,N00276,Variant,Colorectal cancer
501,KEGG_MEDICUS_VARIANT_EML4_ALK_FUSION_KINASE_TO_PI3K_SIGNALING_PATHWAY,N00047,Variant,Non-small cell lung cancer
502,KEGG_MEDICUS_VARIANT_EML4_ALK_FUSION_KINASE_TO_PLCG_ERK_SIGNALING_PATHWAY,N00025,Variant,Non-small cell lung cancer
503,KEGG_MEDICUS_VARIANT_EML4_ALK_FUSION_KINASE_TO_RAS_ERK_SIGNALING_PATHWAY,N00007,Variant,Non-small cell lung cancer
504,KEGG_MEDICUS_VARIANT_ERBB2_OVEREXPRESSION_TO_EGF_JAK_STAT_SIGNALING_PATHWAY,N00095,Variant,Pancreatic cancer
505,KEGG_MEDICUS_VARIANT_ERBB2_OVEREXPRESSION_TO_PI3K_SIGNALING_PATHWAY,N00034,Variant,Pancreatic cancer
506,KEGG_MEDICUS_VARIANT_EREG_OVEREXPRESSION_TO_PI3K_SIGNALING_PATHWAY,N00283,Variant,Colorectal cancer
507,KEGG_MEDICUS_VARIANT_EWSR1_WT1_FUSION_TO_TRANSCRIPTIONAL_ACTIVATION,N00137,Variant,Transcription
508,KEGG_MEDICUS_VARIANT_FZD7_OVEREXPRESSION_TO_WNT_SIGNALING_PATHWAY,N00059,Variant,Hepatocellular carcinoma
509,KEGG_MEDICUS_VARIANT_HRAS_OVEREXPRESSION_TO_ERK_SIGNALING_PATHWAY,N00077,Variant,Bladder cancer
510,KEGG_MEDICUS_VARIANT_IGF2_OVEREXPRESSION_TO_RAS_ERK_SIGNALING_PATHWAY,N00235,Variant,Hepatocellular carcinoma
511,KEGG_MEDICUS_VARIANT_IGH_MMSET_FUSION_TO_TRANSCRIPTIONAL_ACTIVATION,N00125,Variant,Transcription
512,KEGG_MEDICUS_VARIANT_LOSS_OF_CDKN1B_TO_P27_CELL_CYCLE_G1_S,N00093,Variant,Prostate cancer
513,KEGG_MEDICUS_VARIANT_LOSS_OF_RASSF1_TO_RAS_RASSF1_SIGNALING_PATHWAY,N00097,Variant,Non-small cell lung cancer
514,KEGG_MEDICUS_VARIANT_LOSS_OF_VHL_TO_HIF_1_SIGNALING_PATHWAY,N00080,Variant,Renal cell carcinoma
515,KEGG_MEDICUS_VARIANT_LRP6_OVEREXPRESSION_TO_WNT_SIGNALING_PATHWAY,N00060,Variant,Breast cancer
516,KEGG_MEDICUS_VARIANT_MET_OVEREXPRESSION_TO_RAS_ERK_SIGNALING_PATHWAY,N00248,Variant,Hepatocellular carcinoma
517,KEGG_MEDICUS_VARIANT_MLL_AF4_FUSION_TO_TRANSCRIPTIONAL_ACTIVATION,N00119,Variant,Transcription
518,KEGG_MEDICUS_VARIANT_MLL_ENL_FUSION_TO_TRANSCRIPTIONAL_ACTIVATION,N00120,Variant,Transcription
519,KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_CACNA1D_H_TO_ANGIOTENSIN_ALDOSTERONE_SIGNALING_PATHWAY,N00302,Variant,Renin-angiotensin-aldosterone signaling
520,KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_EGFR_TO_PI3K_SIGNALING_PATHWAY,N00036,Variant,Non-small cell lung cancer
521,KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_EGFR_TO_PLCG_ERK_SIGNALING_PATHWAY,N00024,Variant,Non-small cell lung cancer
522,KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_EGFR_TO_RAS_ERK_SIGNALING_PATHWAY,N00014,Variant,Non-small cell lung cancer
523,KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_FGFR3_TO_RAS_ERK_SIGNALING_PATHWAY,N00011,Variant,Bladder cancer
524,KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_GNAS_TO_ACTH_CORTISOL_SIGNALING_PATHWAY,N00321,Variant,Cushing syndrome
525,KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_GNAS_TO_CRHR_PKA_ACTH_SIGNALING_PATHWAY,N00326,Variant,Cushing syndrome
526,KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_GRM1_TO_MGLUR1_TRPC3_SIGNALING_PATHWAY,N00954,Variant,Spinocerebellar ataxia
527,KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_ITPR1_TO_MGLUR1_TRPC3_SIGNALING_PATHWAY,N00958,Variant,Spinocerebellar ataxia
528,KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_KCNJ5_TO_ANGIOTENSIN_ALDOSTERONE_SIGNALING_PATHWAY,N00303,Variant,Renin-angiotensin-aldosterone signaling
529,KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_KIT_TO_PI3K_SIGNALING_PATHWAY,N00046,Variant,Acute myeloid leukemia
530,KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_KIT_TO_RAS_ERK_SIGNALING_PATHWAY,N00003,Variant,Acute myeloid leukemia
531,KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_KRAS_NRAS_TO_ERK_SIGNALING_PATHWAY,N00012,Variant,Colorectal cancer
532,KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_KRAS_NRAS_TO_PI3K_SIGNALING_PATHWAY,N00032,Variant,Colorectal cancer
533,KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_MET_TO_PI3K_SIGNALING_PATHWAY,N00044,Variant,Hepatocellular carcinoma
534,KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_MET_TO_RAS_ERK_SIGNALING_PATHWAY,N00005,Variant,Hepatocellular carcinoma
535,KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_PI3K_TO_PI3K_SIGNALING_PATHWAY,N00049,Variant,Hepatocellular carcinoma
536,KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_PRKACA_TO_ACTH_CORTISOL_SIGNALING_PATHWAY,N00320,Variant,Cushing syndrome
537,KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_RET_TO_PI3K_SIGNALING_PATHWAY,N01065,Variant,PI3K signaling
538,KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_SMO_TO_HEDGEHOG_SIGNALING_PATHWAY,N00017,Variant,Basal cell carcinoma
539,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABBERANT_ATXN2_3_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY,N00957,Variant,Spinocerebellar ataxia
540,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_26S_PROTEASOME_MEDIATED_PROTEIN_DEGRADATION,N01060,Variant,Alzheimer disease
541,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_AGE_RAGE_SIGNALING_PATHWAY,N00996,Variant,Alzheimer disease
542,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_ANTEROGRADE_AXONAL_TRANSPORT,N01018,Variant,Alzheimer disease
543,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_CROSSTALK_BETWEEN_EXTRINSIC_AND_INTRINSIC_APOPTOTIC_PATHWAYS,N01005,Variant,Alzheimer disease
544,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_ELECTRON_TRANSFER_IN_COMPLEX_I,N00997,Variant,Alzheimer disease
545,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_ELECTRON_TRANSFER_IN_COMPLEX_IV,N00999,Variant,Alzheimer disease
546,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_IRE1A_JNK_SIGNALING_PATHWAY,N01014,Variant,Unfolded protein response
547,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_MACHR_CA2_APOPTOTIC_PATHWAY,N01001,Variant,Alzheimer disease
548,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY,N01002,Variant,Alzheimer disease
549,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_TRANSPORT_OF_CALCIUM,N01003,Variant,Alzheimer disease
550,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_VGCC_CA2_APOPTOTIC_PATHWAY_N01004,N01004,Variant,Alzheimer disease
551,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_VGCC_CA2_APOPTOTIC_PATHWAY_N01006,N01006,Variant,Alzheimer disease
552,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ATXN1_TO_RORA_MEDIATED_TRANSCRIPTION,N00966,Variant,Spinocerebellar ataxia
553,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_DCTN1_TO_RETROGRADE_AXONAL_TRANSPORT,N01158,Variant,Amyotrophic lateral sclerosis
554,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_26S_PROTEASOME_MEDIATED_PROTEIN_DEGRADATION,N01061,Variant,Huntington disease
555,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_ANTEROGRADE_AXONAL_TRANSPORT,N00979,Variant,Huntington disease
556,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_AUTOPHAGY_VESICLE_NUCLEATION,N00993,Variant,Huntington disease
557,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_CREB_MEDIATED_TRANSCRIPTION,N00981,Variant,Huntington disease
558,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_ELECTRON_TRANSFER_IN_COMPLEX_III,N00991,Variant,Huntington disease
559,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY,N00985,Variant,Huntington disease
560,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_REST_MEDIATED_TRANSCRIPTIONAL_REPRESSION,N00980,Variant,Huntington disease
561,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_RETROGRADE_AXONAL_TRANSPORT,N00977,Variant,Huntington disease
562,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_TNF_JNK_SIGNALING_PATHWAY,N00992,Variant,Huntington disease
563,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_TRANSPORT_OF_CALCIUM,N00987,Variant,Huntington disease
564,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_PDYN_TO_TRANSPORT_OF_CALCIUM,N00971,Variant,Spinocerebellar ataxia
565,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_PSEN1_TO_ANTEROGRADE_AXONAL_TRANSPORT,N01017,Variant,Alzheimer disease
566,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_PSEN1_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY,N01008,Variant,Alzheimer disease
567,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_PSEN_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY,N01007,Variant,Alzheimer disease
568,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SNCA_TO_26S_PROTEASOME_MEDIATED_PROTEIN_DEGRADATION,N01030,Variant,Parkinson disease
569,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SNCA_TO_ANTEROGRADE_AXONAL_TRANSPORT,N01055,Variant,Parkinson disease
570,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SNCA_TO_ELECTRON_TRANSFER_IN_COMPLEX_I,N01042,Variant,Parkinson disease
571,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SNCA_TO_PERK_ATF4_SIGNALING_PATHWAY,N01035,Variant,Unfolded protein response
572,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SNCA_TO_VGCC_CA2_APOPTOTIC_PATHWAY,N01031,Variant,Parkinson disease
573,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SOD1_TO_26S_PROTEASOME_MEDIATED_PROTEIN_DEGRADATION,N01144,Variant,Amyotrophic lateral sclerosis
574,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SOD1_TO_INTRINSIC_APOPTOTIC_PATHWAY,N01135,Variant,Amyotrophic lateral sclerosis
575,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SOD1_TO_PERK_ATF4_SIGNALING_PATHWAY,N01149,Variant,Unfolded protein response
576,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SOD1_TO_RETROGRADE_AXONAL_TRANSPORT,N01160,Variant,Amyotrophic lateral sclerosis
577,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SPTBN2_TO_MGLUR1_TRPC3_SIGNALING_PATHWAY,N00960,Variant,Spinocerebellar ataxia
578,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_TDP43_TO_ELECTRON_TRANSFER_IN_COMPLEX_I,N01136,Variant,Amyotrophic lateral sclerosis
579,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_TUBA4A_TO_RETROGRADE_AXONAL_TRANSPORT,N01159,Variant,Amyotrophic lateral sclerosis
580,KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_APC_TO_WNT_SIGNALING_PATHWAY,N00057,Variant,Colorectal cancer
581,KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_ATP1A1_TO_ANGIOTENSIN_ALDOSTERONE_SIGNALING_PATHWAY,N00304,Variant,Renin-angiotensin-aldosterone signaling
582,KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_ATP2B3_TO_ANGIOTENSIN_ALDOSTERONE_SIGNALING_PATHWAY,N00305,Variant,Renin-angiotensin-aldosterone signaling
583,KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_ATXN3_TO_AUTOPHAGY_VESICLE_NUCLEATION,N00962,Variant,Spinocerebellar ataxia
584,KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_AXIN_TO_WNT_SIGNALING_PATHWAY,N00242,Variant,Hepatocellular carcinoma
585,KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_DJ1_TO_FAS_JNK_SIGNALING_PATWHAY,N01057,Variant,Parkinson disease
586,KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_FGF17_TO_RAS_ERK_SIGNALING_PATHWAY,N00877,Variant,Hypogonadotropic hypogonadism
587,KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_FGF8_TO_RAS_ERK_SIGNALING_PATHWAY,N00876,Variant,Hypogonadotropic hypogonadism
588,KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_OPTN_TO_PINK_PARKIN_MEDIATED_AUTOPHAGOSOME_FORMATION,N01138,Variant,Amyotrophic lateral sclerosis
589,KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_P62_TO_PINK_PARKIN_MEDIATED_AUTOPHAGOSOME_FORMATION,N01139,Variant,Amyotrophic lateral sclerosis
590,KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_PDE11A_PDE8B_TO_ACTH_CORTISOL_SIGNALING_PATHWAY,N00323,Variant,CRH-ACTH-cortisol signaling
591,KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_PINK1_TO_ELECTRON_TRANSFER_IN_COMPLEX_I,N01043,Variant,Parkinson disease
592,KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_PINK1_TO_INTRINSIC_APOPTOTIC_PATHWAY_N01048,N01048,Variant,Parkinson disease
593,KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_PINK1_TO_INTRINSIC_APOPTOTIC_PATHWAY_N01050,N01050,Variant,Parkinson disease
594,KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_PRKAR1A_TO_ACTH_CORTISOL_SIGNALING_PATHWAY,N00322,Variant,Cushing syndrome
595,KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_PRKAR1A_TO_CRHR_PKA_ACTH_SIGNALING_PATHWAY,N00327,Variant,Cushing syndrome
596,KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_PRKCG_TO_MGLUR1_TRPC3_SIGNALING_PATHWAY,N00955,Variant,Spinocerebellar ataxia
597,KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_PRKN_TO_INTRINSIC_APOPTOTIC_PATHWAY,N01049,Variant,Parkinson disease
598,KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_PROK2_TO_PROK_PRKR_GI_ERK_SIGNALING_PATHWAY,N00880,Variant,Hypogonadotropic hypogonadism
599,KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_PROKR2_TO_PROK_PRKR_GI_ERK_SIGNALING_PATHWAY,N00881,Variant,Hypogonadotropic hypogonadism
600,KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_PTCH1_TO_HEDGEHOG_SIGNALING_PATHWAY,N00010,Variant,Basal cell carcinoma
601,KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_RASD1_TO_CRHR_PKA_ACTH_SIGNALING_PATHWAY,N00325,Variant,CRH-ACTH-cortisol signaling
602,KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_SIGMAR1_TO_CA2_APOPTOTIC_PATHWAY,N01151,Variant,Amyotrophic lateral sclerosis
603,KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_TP53_TO_TRANSCRIPTION,N00115,Variant,Colorectal cancer
604,KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_UBQLN2_TO_26S_PROTEASOME_MEDIATED_PROTEIN_DEGRADATION,N01146,Variant,Amyotrophic lateral sclerosis
605,KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_VCP_TO_26S_PROTEASOME_MEDIATED_PROTEIN_DEGRADATION,N01145,Variant,Amyotrophic lateral sclerosis
606,KEGG_MEDICUS_VARIANT_NOTCH_OVEREXPRESSION_TO_NOTCH_SIGNALING_PATHWAY,N00087,Variant,Breast cancer
607,KEGG_MEDICUS_VARIANT_OLIGOMERIC_CONFORMATION_PRPC_TO_ANTEROGRADE_AXONAL_TRANSPORT,N01202,Variant,Prion disease
608,KEGG_MEDICUS_VARIANT_RET_FUSION_KINASE_TO_RAS_ERK_SIGNALING_PATHWAY,N00008,Variant,Non-small cell lung cancer
609,KEGG_MEDICUS_VARIANT_SCRAPIE_CONFORMATION_PRPSC_TO_26S_PROTEASOME_MEDIATED_PROTEIN_DEGRADATION,N01197,Variant,Prion disease
610,KEGG_MEDICUS_VARIANT_SCRAPIE_CONFORMATION_PRPSC_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY,N01199,Variant,Prion disease
611,KEGG_MEDICUS_VARIANT_SCRAPIE_CONFORMATION_PRPSC_TO_PERK_ATF4_SIGNALING_PATHWAY,N01198,Variant,Unfolded protein response
612,KEGG_MEDICUS_VARIANT_SCRAPIE_CONFORMATION_PRPSC_TO_PRNP_PI3K_NOX2_SIGNALING_PATHWAY,N01205,Variant,Prion disease
613,KEGG_MEDICUS_VARIANT_SCRAPIE_CONFORMATION_PRPSC_TO_TRANSPORT_OF_CALCIUM,N01200,Variant,Prion disease
614,KEGG_MEDICUS_VARIANT_SCRAPIE_CONFORMATION_PRPSC_TO_VGCC_CA2_APOPTOTIC_PATHWAY,N01201,Variant,Prion disease
615,KEGG_MEDICUS_VARIANT_TEL_AML1_FUSION_TO_TRANSCRIPTIONAL_REPRESSION,N00118,Variant,Transcription
616,KEGG_MEDICUS_VARIANT_TGFA_OVEREXPRESSION_TO_PI3K_SIGNALING_PATHWAY,N00232,Variant,Colorectal cancer
617,KEGG_MEDICUS_VARIANT_TMPRSS2_ERG_FUSION_TO_TRANSCRIPTIONAL_ACTIVATION,N00128,Variant,Prostate cancer
618,KEGG_MEDICUS_VARIANT_TRK_FUSION_KINASE_TO_RAS_ERK_SIGNALING_PATHWAY,N00009,Variant,Thyroid cancer
